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Understanding basic molecular mechanisms 
of cell proliferation is of pivotal importance 
in understanding the progression of cancer 
and many other diseases. This thesis provides 
new information on how human cells respond 
to stress and regulate key control points in 
the cell proliferation cycle, and provides novel 
links between RNA and DNA metabolism. 
Thorough understanding of these cellular 
events will provide groundwork for the 
development of cures, especially for cancer.
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ABSTRACT
Cancer is a disease that has puzzled mankind since ancient times.
In a way, it is a disease where evolution takes a leading role in
individual cells of a multicellular organism. These cells, escaped
from an organismal control of proliferation, form complex tissues
with different cell types and even recruit normal cells to support
them. Cancerous cells begin to live a life of their own, usually at
the expense of the organism. Small-scale mutations and whole-
genome rearrangements are the driving force for evolution, as
well as for cancer progression. It is thus of great importance to
understand the mechanisms whereby cells acquire these genetic
alterations.
In this thesis, I describe the synthesis of two studies on molec-
ular functions of Topoisomerase IIE-binding protein 1 (TopBP1)
and one study on DNA polymerase H (DNA pol H). The data re-
veal novel aspects of TopBP1 on cellular stress response (I) and
cell-cycle regulation (II) and biochemically link the core compo-
nents of DNA replication and RNA transcription (III).
TopBP1 is an essential protein controlling cell-cycle progres-
sion, particularly initiation of DNA replication and DNA stress
response during the S phase. A link between high cellular protein
levels of TopBP1 and high differentiation status with shorter pa-
tient survival has been demonstrated previously. To better un-
derstand the biology of high protein levels of TopBP1, genetically
modified cell lines conditionally expressing a wild-type and
DNA damage response deficient mutant of TopBP1 were pre-
pared. The data show that TopBP1 can initiate a nucleolar stress
response, which is a global cellular response to various kinds of
stress conditions. The data also show that the DNA damage re-
sponse  function  of  TopBP1  is  required  for  cells  to  pass  the  re-
striction point and to restrict the firing of new replication origins.
DNA pol H is responsible for the leading strand of DNA syn-
thesis, but it also contributes to genome stability through multi-
ple mechanisms. The finding that DNA pol H and RNA pol II in-
teract throughout the cell cycle provides novel insight into the co-
operation of these seemingly distinct cellular processes.
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As the development of cancer requires proliferating cells, the
molecular mechanisms that control the cell cycle play a central
role in the progression of cancer. Recent developments in this
field suggest that perturbations in the DNA replication pro-
gramme are behind the genomic instability associated with tu-
mours. The results presented in this thesis clarify the mechanisms
controlling cell proliferation and the decision to enter a new cell
cycle. Understanding these cellular events will provide ground-
work for the development of cures, especially for cancer.
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1 Introduction
Life has evolved into a rich diversity on Earth. The survival strat-
egies of organisms seem overwhelming. Yet, all life is based on
principles involving similar organic molecules and their reactions
trapped inside lipid-layered cells. The basic properties are like-
wise fundamental to all life. These include highly ordered struc-
ture, homeostasis, energy utilisation, reproduction, adaptation to
environmental changes, and evolution.
In order to understand how cells function, one must appreci-
ate the fundamental properties within the sub-cellular environ-
ment. Chromatin, nucleic acids, and proteins create a crowded
environment in the nucleus, which affects many of the biochemi-
cal reactions (Richter et al., 2008). Effects of macromolecular
crowding include the inclination to form protein complexes,
slowing down of molecular diffusion, and favouring compart-
mentalisation. Yet, the nucleus is highly dynamic and plastic,
readily responding to changes in the environmental conditions.
Another, related property of sub-cellular architecture is self-or-
ganisation (Misteli, 2001). Although difficult to prove experimen-
tally, the concept of self-organisation provides the rationale for
the observed dynamic and plastic nature of the nucleus. The as-
sembly of self-organising structures is based on molecular inter-
actions, rather than being determined by preformed rigid struc-
tures. Usually, some key components provide a seeding platform
which other components build upon. One example is the nucleo-
lus, which is organised around the nucleolar-organising regions
(NORs), the repeated genes for the production of ribosomal RNA
(rRNA) (McStay & Grummt, 2008). Although they appear static,
sub-nuclear structures are constantly exchanging individual
components, enabling rapid response to changes in the prevailing
conditions.
Biological systems are often referred to being more than the
sum of their parts. This notion stems from the fact that biological
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processes are intertwined in a complex web of interactions, where
removing one component can affect the functioning of the system
more profoundly than initially anticipated (Barabási & Oltvai,
2004). This is also true for sub-cellular molecular events. The
functionality of living organisms relies on inherently scale-free
information networks, which are similar in structure whatever
the scale of inspection. Scale-free networks are composed of hubs
or  nodes  that  have  more  connections  and  are  thus  more  im-
portant than other components. Master regulator genes are an ex-
ample of nodes that control key decisions in the life of any cell.
Many cellular events are profoundly random, or stochastic.
This is more clearly reflected in the gene expression of individual
cells, where high variations are observed between the cells of the
same clonal origin (Raj & van Oudenaarden, 2008).
One last property exists not only in cells but in all life, and that
is cooperation. Cooperation between genes, chromosomes, cells,
and individual organisms is the most fundamental driving force
in evolution (Nowak, 2006). Losing the cooperation between ge-
netic elements within cells and between cells can lead to various
disease states. The most inciting and intriguing, as well as the
most feared, of them all is cancer.
This thesis integrates three studies on the roles of DNA poly-
merase H (DNA pol H) and TopBP1 in the control of cell prolifera-
tion. The studies reveal unexpected links between DNA replica-
tion machinery, cellular control of stress, and the production of
RNA. The introductory chapter is written in order to better un-
derstand the cell cycle and how cells control their proliferation.
The aim is to better understand the molecular mechanisms be-
hind cancer progression. After all, cancer is the best-studied dis-
ease where cell proliferation goes awry.
1.1 HOW DOES CANCER DEVELOP?
Cancer is a genetic disease with as much genetic diversity as there
are cancers (Vogelstein et al., 2013). There are, however, common
phenotypes that define it. Eight cancer-defining characteristics, or
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hallmarks, have been described: sustained proliferative signal-
ling, evading of growth suppressors, resisting cell death, enabling
replicative immortality, inducing angiogenesis, activation of in-
vasion and metastasis, reprogramming energy metabolism, and
evading immune destruction (Hanahan & Weinberg, 2011).
A neoplastic process is initiated when a stem cell or partly dif-
ferentiated stem cell acquires genomic alterations that give a se-
lective growth advantage (clonal evolution), ultimately produc-
ing cell populations that have escaped the organismal control of
proliferation. Accumulation of genomic alterations can in princi-
ple lead to gradual clonal expansion of cancer cells, or gradually
occur in a small subclone that remains in a dormant state until
appearing in a clonal expansion (Greaves & Maley, 2012). The
classic view of cancer progression has been recently challenged
by a finding of a single catastrophic event during cancer cell evo-
lution, which results in massive reorganisation of the genome
(Stephens et al., 2011). However, molecular mechanisms behind
this phenomenon called chromotripsis remain poorly under-
stood.
The improvement of sequencing techniques in the past decade
has allowed systematic sequencing of cancer cells to map muta-
tions that drive cancer progression. Such efforts have provided
the first glimpse of cancer genome landscapes and allowed clas-
sification of cancer-driver mutations in three core cellular pro-
cesses: cell fate, cell survival, and genome maintenance
(Vogelstein et al., 2013). Genes regulating cell fate affect the deci-
sion as to whether to remain in the division cycle as a stem cell or
to differentiate into a specialised, non-dividing cell type. Muta-
tions affecting cell survival belong to a selection of different su-
perfamilies of master regulator genes that integrate extracellular
signals into cell proliferation programmes. These genes belong to
pathways that regulate a cancer cell’s survival in low-nutrient
conditions, stimulate vasculature growth, evade immune de-
struction, inhibit apoptosis, and promote progression in the cell
cycle. The third class of cancer-driver mutations belongs to genes
regulating genome maintenance.
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To achieve malignant status, a neoplastic cell must acquire
multiple mutations in cancer-driver genes (Stratton et al., 2009).
Most cancer-driver genes fall into the category of oncogenes or
tumour suppressors, which increase the selective advantage of
the cell when activated or inactivated by a mutation. The current
understanding is that mutations accumulate over time, with each
subsequent mutation potentially adding to the selective ad-
vantage of the cell. It is thus quite surprising that most cancer cells
contain comparable amounts of mutations to normal cells, when
looked at from the nucleotide level (Stratton, 2011; Wang et al.,
2002). Furthermore, most tumours have only one or two driver-
gene mutations (Vogelstein et al., 2013). Until 2013, a total of 138
driver-gene mutations were discovered in genome-wide se-
quencing studies: 64 oncogenes and 74 tumour suppressors
(Vogelstein et al., 2013). These numbers are surprisingly low. This
may reflect the properties of scale-free cellular networks, where a
small number of nodes is more important than others.
Cancer is a disease targeting regulatory networks, so we might
expect to find more perturbations in these nodes. Most studies
have focused on finding mutations in the genes, and particularly
inside exons. Only 2.94% of the human genome encodes exons of
protein-coding genes (Dunham et al., 2012). We still have a very
limited understanding of the regulatory mechanisms operating in
cells. The human genome has roughly 20,000 protein-coding
genes (Clamp et al., 2007) with up to 19,000 so-called
pseudogenes (Zhang & Gerstein, 2004), many of which are tran-
scribed to RNA. There is vast evidence that pseudogenes regulate
the expression of coding genes (Pink et al., 2011). Pseudogenes
are also found to be deregulated during cancer progression
(Poliseno et al., 2010). Another class of non-protein coding RNAs
with regulatory function is short and long non-coding RNAs
(ncRNA). It is estimated that a 10–20-fold more genomic sequence
is transcribed to long ncRNAs than to protein-coding RNA
(Nagano & Fraser, 2011). An important class of short ncRNAs is
microRNAs (miRNAs), roughly 23 nucleotides in length, that de-
stabilise or repress the translation of the cognate mRNA (Bartel,
2009).
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The interaction among protein coding genes, long ncRNAs,
and pseudogenes is proposed to be entwined in a complex regu-
latory network mediated by miRNAs (Salmena, et al., 2011). Per-
turbations in this network could also play a big part in the for-
mation of cancer. The regulatory aspect is poorly studied in can-
cer  progression,  and  it  could  explain  why  we  see  a  relatively
small amount of cancer-associated mutations in the protein-cod-
ing genes.
The observed mutation rates in neoplastic cells cannot, in most
cases, explain the neoplastic process alone. However, chromoso-
mal changes are elevated in most cancer tissues (Vogelstein et al.,
2013). In a small number of cancers, a higher point mutation rate
is observed due to faulty repair mechanisms. The neoplastic pro-
cess is greatly enhanced by the increased genomic instability
(Lengauer et al., 1998). Genomic instability has long been known
to exist among cancer cells and to contribute to malignancy. In
fact, genomic instability is found in almost all, if not all, cancer
types. Genomic instability is defined as an increased propensity
for mutations or chromosome alterations. This feature serves as
an evolutionary driver for incipient cancer cells to acquire other
cancer hallmarks at more progressed cancers.
What causes the elevated genomic instability in cancer cells?
Recent research suggests that genomic instability is driven
mainly by defects in cellular control of DNA replication
(Macheret & Halazonetis, 2015). Replication is the most suscepti-
ble stage of the cell cycle, where the whole genome becomes ex-
posed to alterations. Misregulated coordination of DNA replica-
tion can result in genome rearrangements. Oncogene expression
leads to a hyperproliferation phenotype, which is associated with
increased DNA damage (Di Micco et al., 2006). While normal cells
enter senescence or apoptosis in response to an increased DNA
replication rate, neoplastic cells, where crucial regulatory path-
ways are already disturbed, may increase genomic instability
through gross chromosomal alterations. Key regulators of the
DNA replication programme are ATR (ataxia telangiectasia mu-
tated and Rad3-related) and Chk1, which prevent replication
stress by preventing over-activation of DNA replication origins
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during the S phase of the cell cycle (Sørensen & Syljuåsen, 2012).
Interestingly, ATR inhibition has been shown to lead to excessive
activation of DNA replication (origin firing), subsequent accumu-
lation of single-stranded DNA (ssDNA), and ultimately DNA
breakage due to exhaustion of protective RPA (replication pro-
tein A), the protein that binds to ssDNA (Toledo et al., 2013). This
replication catastrophe may be behind the massive genome reor-
ganisation in the chromotripsis event.
1.2 CELL-CYCLE CONTROL MECHANISMS
The cell  cycle is  composed of  four phases:  the DNA replication
phase (S), gap phases before (G1) and after (G2) the S phase, and
the mitotic phase (M), which culminates in cytokinesis (Morgan,
2007). An important feature of cell-cycle control is that the key
phases are completed in all-or-none fashion, without the possibil-
ity of turning back. It is detrimental for a cell to start DNA repli-
cation or spindle assembly and then leave the process without
completion. For that reason, robust mechanisms ensure that each
cell-cycle phase is fully completed before the next phase. Feed-
back signalling mechanisms make sure to achieve this switch-like
change from one phase to another. Regulation of major cell cycle
events by the cyclin-Cdk system is a robust and effective signal-
ling network (Obaya & Sedivy, 2002). Cdks (cyclin-dependent ki-
nases) are major cell-cycle effector proteins whose activity is
tightly controlled by the oscillations of cyclin levels.
Oscillation of cell-cycle regulatory proteins requires their
timely destruction in order to reset the system for a new cycle.
This resetting is highly dependent on the activity of APC/C (ana-
phase-promoting complex/cyclosome) (Peters, 2006). The APC/C
complex ubiquitinates key cell-cycle regulators and targets them
for destruction by the 26S proteasome. The APC/C is important
for the initiation of DNA replication, exit from the mitosis, and
the separation of sister chromatids.
Cell-cycle control involves certain key elements, called check-
points, where the cell checks for its competency to continue into
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the next phase of the cycle. The concept of a checkpoint was for-
mulated based on findings of a dependence-relationship between
late and early cell-cycle events (Hartwell & Weinert, 1989). Mul-
tiple checkpoints exist in different phases of the cell cycle. These
act from G1 to G2 to prevent accumulation of DNA damage and
block the cell entry into mitosis (O’Connell et al. 2000; Bartek &
Lukas, 2001). Activated DNA damage checkpoints temporarily
block or slow down the cell cycle to allow time to resolve the
problem before moving to the next cell-cycle phase.
Different from checkpoints is a major decision point in G1, the
restriction point, which controls whether a cell is eligible to enter
the new cell cycle (Blagosklonny & Pardee, 2002). The restriction
point is different from DNA damage checkpoints in that it is not
activated by stress, but is active by default and must be overrid-
den by extra- and intracellular signalling. Before passing the re-
striction point, it is possible for a cell to completely exit from the
cell cycle. Once the decision to pass the restriction point is made,
the process cannot be stopped, but the cells are committed to
eventually divide.
The concept of a restriction point was originally formulated
based on findings made after re-stimulation of growth (Pardee,
1974). At that time it was known that quiescent cells were blocked
somewhere in the G1 phase. After re-stimulation of blocked cells,
there was a consistent time lag before the start of DNA synthesis,
which suggested the existence of a single control point in G1.
1.2.1 Cyclin-Cdk System
The cell cycle is regulated by sequential activation of Cdks. The
activity of Cdks is mainly regulated by association with cyclin-
binding partners, Cdk inhibitors (CKIs), subcellular localisation,
proteolysis, and phosphorylation events (Obaya & Sedivy, 2002).
Cdks are small, with not much more than a catalytic core that is
similar in all Cdks. In mammalian cells, there are four kinases —
Cdk1 (also called Cdc2), Cdk2, Cdk4, and Cdk6 — that are im-
portant in regulating the cell cycle (Morgan, 1997). The two latter
Cdks are needed for regulation of entry into the cell cycle in re-
sponse to external growth factors. Cdk1 and Cdk2 are required to
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Cdk1 (also called Cdc2), Cdk2, Cdk4, and Cdk6 — that are im-
portant in regulating the cell cycle (Morgan, 1997). The two latter
Cdks are needed for regulation of entry into the cell cycle in re-
sponse to external growth factors. Cdk1 and Cdk2 are required to
Introduction
Dissertations in Forestry and Natural Sciences No 213 22
regulate transitions through mitosis and the DNA replication
phase, respectively.
Cyclins are the main regulatory components of Cdks. The con-
centrations of cyclins oscillate throughout the cell cycle to directly
regulate the Cdk activity upon interaction. Cdks are activated by
conformational changes in the protein structure induced by bind-
ing to a cyclin partner (Jeffrey et al., 1995). Three cyclin classes
mainly regulate the mammalian cell cycle: cyclin E (G1/S phase
cyclin), cyclin A (S phase cyclin), and cyclin B (M phase cyclin). A
fourth class of cyclins, cyclin D, controls the entry into the new
cell cycle in response to growth factors. Cyclin E promotes the
start of the DNA replication phase (Ohtsubo et al., 1995), and its
levels peak at the boundary between the G1 and S phases, with
an abrupt drop upon start of the DNA replication. Cyclin A re-
places cyclin E as an essential S phase cyclin after the DNA repli-
cation phase is fully commenced (Girard et al., 1991). Cyclin A
levels remain high through the S and G2 phases. The kinase part-
ner for both cyclin E and A is Cdk2. Mitotic events, the assembly
of mitotic spindle and alignment of chromosomes at metaphase,
are  controlled  by  cyclin  B–Cdk1  (Ohi  & Gould,  1999).  Cyclin  B
levels rise at the end of the G2 phase and peak at metaphase. The
relocalisation of cyclin B to the nucleus marks the start of mitosis.
Full Cdk activation requires not only cyclin binding but also
phosphorylation of the threonine residue adjacent to the Cdk ac-
tive site by the trimeric Cdk-activating kinase (CAK). CAK, com-
posed of Cdk7, cyclin H, and Mat1, can phosphorylate the Cdk
only when bound to cyclin (Lolli & Johnson, 2014). CAK activity
is maintained at a constant high level throughout the cell cycle,
and it is not known exactly why CAK is required for Cdk activa-
tion.
Two inhibitory phosphorylation sites at adjacent threonine
and tyrosine residues at sites 14 and 15, respectively, regulate the
function of Cdks (Morgan, 1997). These phosphorylated residues
are thought to block the ATP orientation in the Cdk. Wee1 and
Myt1 kinases phosphorylate these threonine and tyrosine resi-
dues, respectively. Cdc25 phosphatases are responsible for
dephosphorylation of both of these residues when the cell is
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ready to move on to the next cell-cycle phase (Boutros et al., 2007).
There are three Cdc25 isoenzymes designated Cdc25A, Cdc25B,
and Cdc25C. The first one controls the G1/S transition and the lat-
ter two control the G2/M transition.
An important regulatory layer of Cdk activity is provided by
CKIs, which inhibit Cdk activation by interfering with the inter-
action between Cdk and cyclin. CKIs belong to two families
known as INK4 and Cip/Kip (Besson et al., 2008). INK4 inhibitors
include four members: p16/INK4a, p15/INK4b, p18/INK4c, and
p19/INK4d. INK4 CKIs bind to Cdk4 and Cdk6 and prevent their
association with cyclin D, thus antagonising growth factors. The
Cip/Kip family includes three members: p21, p27, and p57, which
control proliferation at times of cellular stress and during devel-
opment and differentiation. Cell-cycle regulation during embry-
onic development is regulated by p57, whereas p27 prevents S
phase entry in quiescent cells and p21 mediates DNA damage-
induced cell-cycle arrest. In certain circumstances, p21 and p27
can also promote S phase entry by stabilising intrinsically unsta-
ble cyclin D–Cdk4/6 complexes. These ostensibly contradictory
functions of p21 and p27 create robust signal amplification at
G1/S transition. Extracellular mitogens stimulate cyclin D levels,
and these cyclins also sequester p21 and p27 from the inhibitory
interaction between cyclin–Cdk2. Conversely, anti-mitogens dis-
rupt the cyclin D–Cdk4/6 complexes, thus releasing p21 and p27,
which are then free to further inhibit cyclin E/A–Cdk2.
1.2.2 Restriction Point and DNA Damage Checkpoints
The transition through the restriction point is stimulated by mi-
togens and other growth factor cues, many of which involve the
master regulatory pathways perturbed in cancers (Pardee, 1989).
The period in G1 before the restriction point is the only stage of
the cell cycle that is controlled by growth factors. The regulatory
network behind the restriction point control is overwhelmingly
complex and involves several positive and negative feedback
loops (Blagosklonny & Pardee, 2002). In the focal point of this
control are the Rb (retinoblastoma) protein and E2F transcription
factors. E2F and Rb operate as a bistable switch, resulting in an
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ready to move on to the next cell-cycle phase (Boutros et al., 2007).
There are three Cdc25 isoenzymes designated Cdc25A, Cdc25B,
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include four members: p16/INK4a, p15/INK4b, p18/INK4c, and
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interaction between cyclin–Cdk2. Conversely, anti-mitogens dis-
rupt the cyclin D–Cdk4/6 complexes, thus releasing p21 and p27,
which are then free to further inhibit cyclin E/A–Cdk2.
1.2.2 Restriction Point and DNA Damage Checkpoints
The transition through the restriction point is stimulated by mi-
togens and other growth factor cues, many of which involve the
master regulatory pathways perturbed in cancers (Pardee, 1989).
The period in G1 before the restriction point is the only stage of
the cell cycle that is controlled by growth factors. The regulatory
network behind the restriction point control is overwhelmingly
complex and involves several positive and negative feedback
loops (Blagosklonny & Pardee, 2002). In the focal point of this
control are the Rb (retinoblastoma) protein and E2F transcription
factors. E2F and Rb operate as a bistable switch, resulting in an
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all-or-nothing response that prevents the cell cycle from turning
backwards (Yao et al., 2008).
Rb is a negative regulator of cell cycle, and it acts by inhibiting
E2F transcription factors (Polager & Ginsberg, 2008). Rb phos-
phorylation is required for the release of the inhibitory interaction
with E2Fs and the progress in the cell cycle. The E2F family con-
tains nine proteins (E2F1–8, including E2F3a and E2F3b, pro-
duced by the use of alternate promoters), which either activate or
repress a vast array of cell-cycle-related genes. Traditionally,
E2F1, E2F2, and E2F3a are considered activator E2Fs, and E2F4–
8 repressor E2Fs, although this is likely to be an oversimplifica-
tion. The outcomes of E2F action include the ostensibly contradic-
tory induction of cell proliferation and apoptosis (Bracken et al.,
2004).
The Rb family of proteins contains Rb, p130, and p107. Rb pro-
teins form complexes with E2F proteins, which then bind to E2F-
responsive promoters to recruit histone deacetylases and other
chromatin remodelling factors repressing the E2F1-dependent
transcription and their activity (Sherr & McCormick, 2002). As the
cells are stimulated to progress in the cell cycle, mitogens induce
the expression of cyclin D-Cdk4/Cdk6, which phosphorylate Rb,
preventing the interaction between Rb and E2F. Activated E2F
then upregulates genes required for S phase and cell-cycle pro-
gression, including DNA polymerases, Mcm (Minichromosome
maintenance) proteins, Cdc6, and cyclin E (Bracken et al., 2004).
Cyclin E is important for G1/S transition, where it further inacti-
vates Rb by phosphorylation and initiates the DNA synthesis.
An important master regulator affecting restriction point deci-
sion is the c-Myc transcription factor (Blagosklonny & Pardee,
2002). It is a strong driver for cell proliferation and promotes
passing of the restriction point by stimulating cyclin–Cdk and
E2F activity at several locations in the pathway.
When the cell experiences DNA stress, the DNA damage
checkpoint temporarily halts the progress in the cell cycle. These
checkpoints can be activated in a rapid or delayed manner, de-
pending on the persistence of the DNA damage (Kastan & Bartek,
2004). Rapid response relies on the direct sensing of DNA lesions,
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with signalling mainly mediated by ATR and ATM (ataxia telan-
giectasia mutated) kinases, and leading to phosphorylation of tar-
get proteins. Delayed response is propagated by the p53 tumour
suppressor, leading to transcriptional activation of DNA damage
response target genes.
The types of DNA lesions signalled by ATM and ATR fall into
two broad categories: DNA double-strand breaks and the lesions
that block DNA replication machinery, respectively. ATR is more
important for cell proliferation, which is reflected by the fact that
ATR is indispensable for the cells (Cortez et al., 2001; Brown &
Baltimore, 2003). In contrast, cells can live without ATM. ATR is
activated by ssDNA that is generated by uncoupling of the DNA
polymerase and the replicative helicase (Byun et al., 2005). DNA
double-strand break (DSB) is signalled to ATM through changes
in chromosome conformation. This is an extremely sensitive
mechanism, since one or two breaks are sufficient for partial acti-
vation of ATM, and full ATM response can be achieved with less
than 20 breaks (Bakkenist & Kastan, 2003). ATM exists in an inac-
tive state as a dimer, which is dissociated by autophosphorylation
of serine residue at 1981 in response to chromatin breaks. Both
ATR and ATM signalling ultimately target Cdc25, which inhibits
Cdks and thus blocks the progression in the cell cycle.
Tumour suppressor p53 is in the central control of many deci-
sions during cellular stress (Levine, 1997). The p53 can contribute
to cell-cycle block to guide the cell to permanently exit from the
cell cycle (senescence) or to commit apoptosis. In addition, it can
activate several DNA repair pathways. The p53 controls these de-
cisions mostly through its transcriptional regulation of hundreds
of different target genes.
The protein levels of p53 are actively suppressed in cells
through mechanisms that involve Mdm2 and Mdm4 ubiquitin
ligases (Meek, 2009). These proteins target p53 into proteasomal
destruction. By default, p53 response is actively prevented in
cells. Activation of p53 results primarily from the elevation of p53
protein levels (stabilisation) due to disruption of the inhibitory
interaction between Mdm2 and p53 and through pathways con-
trolled by nucleoli.
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The stability of p53 is also controlled through the ARF tumour
suppressor pathway (Sherr & Weber, 2000). ARF is an alternate
reading frame protein product of the CDKN2a (cyclin-dependent
kinase 2a) locus. The other protein product of this locus is INK4a.
ARF is normally expressed at low levels but increased in response
to hyperproliferative signals and oncoproteins, such as Myc, Ras,
and v-Abl. ARF blocks the ubiquitin ligase activity of Mdm2, un-
couples the interaction between Mdm2 and p53, and sequesters
Mdm2 to the nucleolus.
The p53 responds to a wide variety of cellular stresses, includ-
ing DNA damage, hyperproliferation, heat shock, hypoxia, and
oxidative stress.  Primary DNA damage regulator kinases,  ATR,
and ATM also control p53 response by phosphorylating specific
p53 residues that affect its stability (Niida & Nakanishi, 2006).
The complexity of the p53 activation network is enormous. p53
activation is regulated by numerous positive and negative feed-
back loops (Lavin & Gueven, 2006). However, there is remarkable
simplicity in the activation of p53. It appears that the nucleolus
plays an important role in p53 activation. Many, if not all, agents
or stress conditions reported to lead to activation of p53 also dis-
rupt the nucleolus. Rubbi and Milner (2003) showed that even a
large amount of DNA damage does not lead to p53 stabilisation
unless the nucleolus is also disrupted. Conversely, forcing nucle-
olar disruption by microinjection of anti-UBF (upstream binding
factor) antibodies leads to stabilisation of p53. UBF is an im-
portant regulatory protein binding to rDNA (ribosomal DNA)
that defines the nucleolar structure. Thus, it seems that the central
role of nucleoli in the cell’s metabolism is exploited in activation
of p53 response (Vlatkovi� et al., 2014).
The p53 participates in the regulation of multiple transcrip-
tional networks (Riley et al., 2008). Although p53 levels have tra-
ditionally been considered to be continuously suppressed in un-
stressed cells, the regulation of p53 levels is more dynamic. By
inspecting individual cells, Loewer et al. (2010) showed that p53
levels oscillate in proliferating cells during non-stressed condi-
tions. These oscillations were pinpointed to be the result of spon-
taneous DSBs and ATM activation probably occurring during
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DNA replication. These pulses did not result in cell-cycle arrest,
which required a more sustained p53 signalling. In a follow-up
study, the authors showed that the dynamics of p53, rather than
absolute levels, determine the gene expression (Purvis et al.,
2012). In fact, these kinds of oscillations are found with many
gene products and probably reflect the stochastic nature of gene
expression more widely (Raj & van Oudenaarden, 2008).
Precise regulation of the cell cycle is essential for maintaining
homeostasis in multicellular animals. Escape from this regulation
is a pre-requisite for development of cancer. Emerging strategies
to treat cancer include preventing the cell cycle reaching comple-
tion (Dominguez-Brauer et al., 2015). The major challenge in these
strategies is how to distinguish normal and cancer cells. Increased
genomic instability in cancer cells could be a distinguishing fac-
tor, but more basic research is needed to increase our understand-
ing of the basic mechanisms how cells control proliferation.
1.3 DNA REPLICATION
DNA replication is initiated from multiple points in the genome
(Fragkos et al., 2015). The initiation process follows a tightly con-
trolled schedule that ensures accuracy and completeness of the
replication within a fixed time limit. Multiple replication start
sites are needed in order to reduce the time required to duplicate
the whole human genome. Extra precaution is taken to prevent
duplication of any region more than once. Re-duplication is pre-
vented by regulating two major steps in the initiation of DNA
replication. First, the marking of potential replication origins and
the assembly of pre-replication complexes (pre-RC) (replication
licensing) occurs in late M and early G1 phases (Diffley, 2004).
Replication licensing occurs only when Cdk activity is low. Sec-
ond, the assembly of pre-initiation complex (pre-IC) and origin
firing in the late G1 phase occurs in high Cdk activity and when
APC/C is inactivated. This mechanism ensures that any marked
origin can only fire once.
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A key step in the initiation of DNA replication is the assembly
of the replicative helicase, which coordinates the progression of
the replication forks through the leading strand polymerase and
integrates other essential interactions within the moving repli-
some. These include interactions with the systems establishing
sister chromatid cohesion, histone assembly, and DNA damage
checkpoint (Gambus et al., 2006).
1.3.1 Replication Licensing
Assembly of pre-RC starts by binding the six subunit ORC (origin
recognition complex) to potential replication origins. ORC catal-
yses pre-RC assembly by recruiting Cdt1 (Cdc10-dependent tran-
script 1) and Cdc6, which in turn completes the process of repli-
cation licensing by recruiting the core components of the replica-
tive helicase, six-subunit Mcm2–7 complex (Masai et al., 2010).
ORC is the only component that is thought to link the genomic
sites with DNA replication initiation (Méchali, 2010). In contrast
to budding yeast, where consensus sequences define the origin
choice, metazoan genomes do not have any specific sequence that
would  define  where  ORC  binds.  CpG  islands  (Delgado  et  al.,
1998), transcriptional regulatory elements (Cadoret et al., 2008),
and G4 quadruplexes (Besnard et al., 2012) are often associated
with metazoan origins. Still, the exact nature of DNA replication
origins remains disputed. Studies have been hampered by the
ORC’s replication-independent roles in establishment and
maintenance of transcriptionally silent heterochromatin, chroma-
tin cohesion, and cytokinesis (Sasaki & Gilbert, 2007). Yet, early
replication initiation events are known to occur in open, tran-
scriptionally active chromatin regions (Barlow & Nussenzweig,
2014). The requirement for many factors, such as sequence, chro-
matin context, and associated proteins, shows the modularity of
origin usage (Méchali, 2010). This creates necessary plasticity for
initiation of DNA replication, providing adaptability to environ-
mental conditions, chromatin structure, and cell-specific needs.
The assembly of pre-RC is ready upon loading of the Mcm
complex, leaving the origin fully licensed for initiation. The Mcm
complex, however, remains as an inactive double-hexamer and
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requires additional components for the activation. Only a small
fraction of assembled pre-RCs are ultimately used to activate rep-
lication in the S phase. Inactive, dormant origins are needed in
case of fork stalling or collapse, which frequently take place dur-
ing normal replication (Sørensen & Syljuåsen, 2012).
Assembly of pre-RC occurs when APC/C levels are high and
Cdk levels are low in the late M and early G1 phases, providing
the basic framework for preventing re-licensing of origins during
later phases of the cell cycle (Diffley, 2004). APC/C is required to
eliminate cyclins and geminin at the end of the M phase. Geminin
is an inhibitor of replication licensing, and its activity is greatest
during the S–M phases of the cell cycle (McGarry & Kirschner,
1998). It binds to Cdt1 and inhibits Cdt1 association with ORC
(Wohlschlegel et al., 2000). APC/C ubiquitinates geminin in the
G1 phase and targets it for degradation (McGarry & Kirschner,
1998). Origin licensing outside the late M and early G1 phases is
regulated on multiple levels to efficiently prevent re-duplication
of the genome.
1.3.2 Initiation of DNA Replication
Eukaryotic DNA replication initiation requires unwinding of the
DNA duplex by the replicative helicase and activation of three
different polymerases. One polymerase (DNA pol D/primase) is
specialised in synthesising short DNA/RNA primers for the other
two polymerases that cannot initiate DNA synthesis. DNA pol G
and H are required to duplicate the bulk of the genome in the lag-
ging and leading strand, respectively (Pursell et al., 2007;
McElhinny et al., 2008). However, only DNA pol H seems  to  be
required for initiation as part of the pre-IC (Yeeles et al., 2015).
Replication origins are fired in clusters, and they can be ob-
served as separate replication foci (replication factories) under
microscopy. The temporal programme of early and late origin fir-
ing  is  still  disputed,  and  it  seems  that  in  mammals  it  is  highly
plastic without any true sequence specificity that would deter-
mine  which  origins  fire  early  and  which  fire  late  during  the  S
phase (Méchali, 2010).
Introduction
Dissertations in Forestry and Natural Sciences No 213 28
A key step in the initiation of DNA replication is the assembly
of the replicative helicase, which coordinates the progression of
the replication forks through the leading strand polymerase and
integrates other essential interactions within the moving repli-
some. These include interactions with the systems establishing
sister chromatid cohesion, histone assembly, and DNA damage
checkpoint (Gambus et al., 2006).
1.3.1 Replication Licensing
Assembly of pre-RC starts by binding the six subunit ORC (origin
recognition complex) to potential replication origins. ORC catal-
yses pre-RC assembly by recruiting Cdt1 (Cdc10-dependent tran-
script 1) and Cdc6, which in turn completes the process of repli-
cation licensing by recruiting the core components of the replica-
tive helicase, six-subunit Mcm2–7 complex (Masai et al., 2010).
ORC is the only component that is thought to link the genomic
sites with DNA replication initiation (Méchali, 2010). In contrast
to budding yeast, where consensus sequences define the origin
choice, metazoan genomes do not have any specific sequence that
would  define  where  ORC  binds.  CpG  islands  (Delgado  et  al.,
1998), transcriptional regulatory elements (Cadoret et al., 2008),
and G4 quadruplexes (Besnard et al., 2012) are often associated
with metazoan origins. Still, the exact nature of DNA replication
origins remains disputed. Studies have been hampered by the
ORC’s replication-independent roles in establishment and
maintenance of transcriptionally silent heterochromatin, chroma-
tin cohesion, and cytokinesis (Sasaki & Gilbert, 2007). Yet, early
replication initiation events are known to occur in open, tran-
scriptionally active chromatin regions (Barlow & Nussenzweig,
2014). The requirement for many factors, such as sequence, chro-
matin context, and associated proteins, shows the modularity of
origin usage (Méchali, 2010). This creates necessary plasticity for
initiation of DNA replication, providing adaptability to environ-
mental conditions, chromatin structure, and cell-specific needs.
The assembly of pre-RC is ready upon loading of the Mcm
complex, leaving the origin fully licensed for initiation. The Mcm
complex, however, remains as an inactive double-hexamer and
Miiko Sokka: DNA Polymerase Epsilon and TopBP1
29 Dissertations in Forestry and Natural Sciences No 213
requires additional components for the activation. Only a small
fraction of assembled pre-RCs are ultimately used to activate rep-
lication in the S phase. Inactive, dormant origins are needed in
case of fork stalling or collapse, which frequently take place dur-
ing normal replication (Sørensen & Syljuåsen, 2012).
Assembly of pre-RC occurs when APC/C levels are high and
Cdk levels are low in the late M and early G1 phases, providing
the basic framework for preventing re-licensing of origins during
later phases of the cell cycle (Diffley, 2004). APC/C is required to
eliminate cyclins and geminin at the end of the M phase. Geminin
is an inhibitor of replication licensing, and its activity is greatest
during the S–M phases of the cell cycle (McGarry & Kirschner,
1998). It binds to Cdt1 and inhibits Cdt1 association with ORC
(Wohlschlegel et al., 2000). APC/C ubiquitinates geminin in the
G1 phase and targets it for degradation (McGarry & Kirschner,
1998). Origin licensing outside the late M and early G1 phases is
regulated on multiple levels to efficiently prevent re-duplication
of the genome.
1.3.2 Initiation of DNA Replication
Eukaryotic DNA replication initiation requires unwinding of the
DNA duplex by the replicative helicase and activation of three
different polymerases. One polymerase (DNA pol D/primase) is
specialised in synthesising short DNA/RNA primers for the other
two polymerases that cannot initiate DNA synthesis. DNA pol G
and H are required to duplicate the bulk of the genome in the lag-
ging and leading strand, respectively (Pursell et al., 2007;
McElhinny et al., 2008). However, only DNA pol H seems  to  be
required for initiation as part of the pre-IC (Yeeles et al., 2015).
Replication origins are fired in clusters, and they can be ob-
served as separate replication foci (replication factories) under
microscopy. The temporal programme of early and late origin fir-
ing  is  still  disputed,  and  it  seems  that  in  mammals  it  is  highly
plastic without any true sequence specificity that would deter-
mine  which  origins  fire  early  and  which  fire  late  during  the  S
phase (Méchali, 2010).
Introduction
Dissertations in Forestry and Natural Sciences No 213 30
DNA replication  begins  by  assembly  of  the  pre-IC,  which  is
the protein complex bound at the origin before initiation of DNA
replication. The core components of pre-IC are the replicative hel-
icase complex CMG [Cdc45 (cell division cycle 45), Mcm2–7, and
GINS (go–ichi–ni–san complex)] and the leading-strand DNA pol
H (Yeeles et al., 2015). Pre-IC assembly requires the activity of both
Cdk and Cdc7/Dbf4-dependent (DDK) kinases. A key step in pre-
IC assembly is the formation of the CMG complex. The critical
point in the initiation is the loading of Cdc45 onto chromatin,
which is reflected by the fact that Cdc45 is the limiting factor for
DNA replication (Wong et al., 2011).
Initiation events are understood much better in budding yeast
than in vertebrates. A milestone has been recently achieved with
the reconstitution of the Saccharomyces cerevisiae replication initi-
ation factors in vitro (Yeeles et al., 2015). The CMG assembly be-
gins when DDK phosphorylates Mcm and allows the loading of
Sld3/7 (Sld, synthetically lethal to Dpb11-1) and Cdc45 (Masai et
al., 2006; Sheu & Stillman, 2006; Yeeles et al., 2015). The remaining
essential replication factors (Sld2, Dpb11, GINS, DNA pol H, and
Mcm10) are loaded in a DDK- and Cdk-dependent manner
(Yeeles et al., 2015). DNA pol H,  Dpb11,  Sld2,  and GINS form a
pre-loading complex before they assemble at the origins
(Muramatsu et al., 2010). This complex formation requires Cdk,
but not DDK activity. Importantly, the molecular switch that
turns on DNA replication requires the docking of Cdk-phosphor-
ylated forms of Sld2 and Sld3 by the scaffolding protein Dpb11
(Tanaka et al., 2007; Zegerman & Diffley, 2007). Dpb11 is an inte-
gral part of the replication initiation that brings the interactions
with other initiation factors together.
DNA replication is considered to begin when the replicative
CMG helicase is activated. The leading strand DNA pol H remains
associated with the CMG as the replication proceeds (Sengupta et
al., 2013; Langston et al., 2014). However, the critical loading fac-
tors, such as Dpb11, Sld2, and Sld3, are not part of this replisome
complex (Gambus et al., 2006).
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Much of our understanding of the replication initiation in ver-
tebrates is based on studies of the Xenopus replication system. Alt-
hough it  is  a  special  case with fast  replication cycle,  it  seems to
resemble human replication initiation fairly well. Besides having
rapid cell division, the main difference to cultured cells is that the
Xenopus cell cycle lacks DNA replication checkpoints (Hartwell &
Weinert, 1989). They also rely mainly on maternally produced
proteins without the need for protein synthesis.
TopBP1, the human homologue of yeast Dpb11, performs a
similar scaffolding function in initiation of replication (Wardlaw
et al., 2014). However, TopBP1 is nearly double the size with nine
BRCT (BRCA1 C-terminal) domains compared to four in Dpb11
(see Figure 2 for the domain structure of TopBP1). TopBP1 is thus
likely to possess a larger interaction network than Dpb11. It is not
entirely clear how much replication initiation in human or verte-
brate cells compares to that of yeast. At least, Sld3 seems to be
conserved fairly well in humans as the Treslin homologue (Boos
et al., 2011).
TopBP1 and Treslin bind independently to the replication ori-
gins (Kumagai et al., 2010). It appears that these two proteins
form a complex after their binding to chromatin. Cdk2 is neces-
sary for the formation of this complex. Treslin is phosphorylated
by Cdk2 and interacts with both TopBP1 BRCT domains 1–2 and
Cdc45 (Kumagai et al., 2010; Kumagai et al., 2011). The same re-
gion is required for the checkpoint activation of TopBP1
(Delacroix et al., 2007; Lee et al., 2007). It is likely that DNA repli-
cation initiation events are negatively regulated by TopBP1 when
the DNA damage checkpoint is active. Like Dpb11, TopBP1 has
also been found to interact with DNA pol H (Mäkiniemi et al.,
2001), but the exact molecular nature of the interaction in human
cells remains to be determined.
Treslin interacts directly with Chk1, and this interaction inhib-
its Cdc45 loading and thus firing of the replication fork (Guo et
al., 2015). Elimination of the Treslin-Chk1 interaction leads to in-
creased firing of replication forks, suggesting that Chk1 regulates
the replication timing programme in a normal, unperturbed cell
cycle.
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Additional players have been found in vertebrate replication
initiation. In the Xenopus replication system, TopBP1 promotes
binding of GEMC1 (geminin coiled-coil containing protein 1) to
chromatin by directly interacting with GEMC1. Thereupon,
GEMC1 interacts with Cdc45 and cyclin E-Cdk2. Cyclin E-Cdk2
strongly phosphorylates GEMC1, which stimulates initiation of
DNA replication (Balestrini et al., 2010).
After the initiation of replication, the DNA duplex is unwound
by  the  CMG  replicative  helicase.  It  is  still  not  known  how  the
DNA duplex is unwound exactly. Unwinding creates a region of
ssDNA which is rapidly coated by RPA. Cdc45 may function as a
passive molecular wedge during the strand separation, simulta-
neously loading RPA on the lagging strand (Szambowska et al.,
2014). Xenopus RECQL4 (RecQ helicase-like 4) homolog xRTS has
been shown to be required for RPA loading on chromatin
(Sangrithi et al., 2005). RECQL4 loading onto chromatin takes
place after pre-RC formation and after the loading of TopBP1,
GINS, and Cdc45. Moreover, xRTS loading onto chromatin is in-
dependent of cyclin-Cdk activity.
Xenopus TopBP1  binds  chromatin  in  two  modes.  A  small
amount of TopBP1 binds independently of S phase Cdk activity,
and this is sufficient to support a normal amount of DNA repli-
cation (Hashimoto & Takisawa, 2003). More TopBP1 is recruited
after the S phase Cdk activation and after the G1/S transition. This
likely reflects the fact that TopBP1 is required to prevent DSB ac-
cumulation during the S phase, making sure that DNA replica-
tion is appropriately completed (Kim et al., 2005).
1.3.3 Regulation of DNA Replication
During the DNA replication phase, the genome experiences mas-
sive restructuring as the chromatin is unpacked and the DNA is
unwound. However, the processes behind chromatin reorganisa-
tion during DNA replication are poorly understood. A replica-
tion programme proceeds in a phase-like manner, which is
tightly regulated in space and time. Multiple replication forks
converge at the replication factories, which can be visualised as
focal points under light microscopy (Gillespie & Blow, 2010).
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The firing of new replication forks and activation of new rep-
lication clusters are regulated by the ATR network. Although
ATR  is  better  known  from  its  DNA  damage  response  activity,
ATR is  required to monitor DNA replication also under unper-
turbed conditions, inhibiting excess and untimely firing of repli-
cation forks (Sørensen & Syljuåsen, 2012).
Progression of replication forks can stall if the replication ap-
paratus encounters bulky DNA lesions or other obstacles such as
transcription apparatus, unusual secondary structures, or DNA
binding proteins in the DNA. Stress-responsive mechanisms try
to stabilise the stalled fork and facilitate repair and replication re-
start. If restart is not possible, forks may collapse, which can fur-
ther be processed into DSBs. Formation of replication-induced
DSBs is common during the S phase, reflecting the complex and
difficult task of duplicating the genome.
Although the components of the replisome are poorly known
in any system, it is much better understood in yeast than in ver-
tebrates. The 5’ to 3’ directionality of DNA synthesis of all eukar-
yotic polymerases leads to continuous leading strand synthesis,
whereas the complementary lagging strand is replicated in a dis-
continuous manner. The lagging strand is replicated in short
stretches of DNA called Okazaki fragments by the DNA pol G
(McElhinny et al., 2008). The leading strand is synthesised by
DNA pol H (Pursell et al., 2007). DNA pol G requires PCNA (pro-
liferating cell nuclear antigen) in order to be processive, while it
is not required for DNA pol H processivity (Syvaoja et al., 1990).
As a trimeric protein encircling the DNA, it is thought that PCNA
prevents dissociation of the DNA pol G from the DNA. PCNA is
loaded by RFC (replication factor C) after the DNA pol D/primase
has synthesised the primer DNA. Although DNA pol H interacts
with the PCNA, it seems that it is interaction with the CMG that
provides the necessary processivity for DNA pol H. Indeed, DNA
pol G–PCNA and DNA pol H–CMG complexes seem to be in-
volved in a specific suppression mechanism that prevents repli-
cation by DNA pol H or G at the wrong DNA strand (Georgescu et
al., 2014, 2015).
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The signal that initiates the S phase checkpoint response is
ssDNA generated by the functional uncoupling of helicase and
polymerase activities (Byun et al., 2005). The ssDNA is rapidly
bound by RPA and the 9-1-1 (Rad9-Rad1-Hus1) checkpoint
clamp, resulting in activation of ATR. It may be that ssDNA alone
is not sufficient for the checkpoint signalling, but requires the ac-
tivity of DNA pol D at the lagging strand (Masai et al., 2010).
TopBP1 is also required for ATR activation, but both proteins are
recruited independently to chromatin (Cimprich & Cortez, 2008;
Sokka et al., 2010). ATR is recruited by ssDNA-bound RPA, and
TopBP1 needs 9–1–1 for chromatin binding. The 9–1–1 is loaded
to the 5’ junctions between ssDNA and dsDNA by the clamp
loader Rad17-RFC. Rad17 and Rad9 are phosphorylated by ATR,
which enhances TopBP1 recruitment, possibly creating a positive
feedback loop. ATR acts by phosphorylating multiple substrates,
and one of the main effects is the inhibition of new replication
factory activation. ATR activates Chk1, which in turn inhibits rep-
lication  fork  firing  by  phosphorylating  Cdc25A.  This  directs
Cdc25A into proteolysis, leaving Cdk2 inactive and unable to in-
itiate new replication factories as part of the cyclin E complex.
The involvement of DNA pol H in the DNA damage checkpoint
has been suggested even before it was known that DNA pol H is
the leading strand polymerase (Navas et al., 1995). The yeast
checkpoint mediator Mrc1 is part of the replisome complex and
interacts with the DNA pol H and Mcm, possibly modulating the
coupling of unwinding and polymerisation at the replication fork
(Gambus et al., 2006; Lou et al., 2008). The human homologue of
Mrc1, the Claspin, is an important regulator of ATR response
functioning downstream of TopBP1 (Liu et al., 2006).
1.4 RNA TRANSCRIPTION AND CELL-CYCLE CONTROL
Along with DNA replication, RNA transcription requires the un-
packing of the condensed chromatin and unwinding of the DNA
double helix. This exposes ssDNA to breaks and modifications. It
is thus vital for cells to regulate RNA transcription precisely in
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order to minimise DNA damage. Cells produce two types of
RNAs that are classified as protein-coding and ncRNAs.
Three functionally different DNA-dependent RNA polymer-
ases exist in humans, namely RNA pol I, II, and III. RNA pol II
transcribes all the protein coding genes but also many genes for
ncRNAs. RNA pol I and III express only the ncRNAs. Together,
RNA pol I and III produce the vast majority of the RNA content
of the cell.
Transcripts produced by RNA pol III are all short and non-
translated. The main transcripts are the 5S rRNA and transfer
RNA. However, the majority of the rRNA is produced by RNA
pol I in nucleoli, which are formed around rDNA genes, or NORs.
RNA pol I and III are aberrantly expressed in a variety of cancers
and their transcript levels can have a great impact on cell growth
(White, 2008). It is easy to think that changes in rRNA levels in
rapidly proliferating cancer cells are due to increased demand for
protein synthesis. However, growing evidence suggests that nu-
cleoli play an active role in tumorigenesis (Montanaro et al.,
2008). Many oncogenes and tumour suppressors regulate the
transcription by RNA pol I and III (White, 2008). Thus, the regu-
lation of these two RNA polymerases seems to be integral in the
control of cell growth and in relevance to cancer.
1.4.1 Nucleolus as a Central Hub for Stress Response
The most prominent nuclear body is the nucleolus, where rRNA
transcription, processing, and ribosome assembly take place
(Raška et al., 2006). Nucleolar functions related to ribosome bio-
genesis are further separated into three distinct structural com-
partments: the fibrillar centre (FC), the dense fibrillar component
(DFC), and the granular component (GC). RNA pol I-driven
rRNA synthesis  takes place in the FC. The precursor 45S rRNA
(pre-rRNA) is then processed in the DFC, and pre-ribosome sub-
units  are  finally  assembled  in  the  GC.  The  nucleolus  was  long
thought to be responsible for ribosome biogenesis and assembly
only, but this view has changed as it has become evident that only
30% of the nucleolar proteome is related in any way to ribosome
biogenesis (Andersen et al., 2002; Scherl et al., 2002).
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Rapidly proliferating cells have enlarged and more numerous
nucleoli. For decades, the number and size of nucleoli have been
markers for the aggressiveness of cancer (Derenzini et al., 2009).
However, the importance of nucleoli in cancer progression has
been overlooked by considering nucleolar changes as a passive,
bystander phenomenon (Hein et al., 2013). Only in recent years
has it become established that the nucleolus is an important reg-
ulator of overall health of the cell (Tsai & Pederson, 2014).
The high demand for ribosomes in a growing cell  places the
nucleolus at centre stage in controlling the cell cycle (Rudra &
Warner, 2004). Nucleoli are extremely sensitive to various kinds
of cellular stress, which initiate a nucleolar stress response that is
characterised by downregulation of rRNA synthesis (Mayer &
Grummt, 2005) and reorganisation of nucleolar components
(Boulon et al., 2010; Vlatkovi� et al., 2014). The end result of nu-
cleolar stress response is the stabilisation of tumour suppressor
p53 and subsequent cell-cycle arrest (Vlatkovi� et al., 2014). The
nucleolar stress response can be initiated by damaging the nucle-
olar DNA or disrupting the structure of nucleoli (Rubbi & Milner,
2003). One of the major pathways of nucleolar stress response is
initiated by inhibition of transcription by RNA pol I.
1.4.2 RNA Polymerase II
RNA pol II is mainly responsible for the transcription of protein-
coding genes in all eukaryotes. This transcription is regulated in
a cell cycle-dependent manner (Cho et al., 2001). For example,
DNA replication and DNA damage response genes are strongly
upregulated in the late G1 and S phases.
RNA pol II is a multi-subunit protein complex. The largest
subunit of RNA pol II shares homology with other RNA polymer-
ases found in humans, but it has a distinct regulatory feature. The
C-terminal domain (CTD) of RNA pol II is a flexible domain com-
prised of up to 52 tandemly repeated heptapeptides in the mam-
malian protein (Egloff & Murphy, 2008). CTD is thought to gen-
erate a phosphopeptide code which regulates the timing of events
throughout the transcription process. Proteins that bind to CTD
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are involved not only in RNA transcription, but also in RNA pro-
cessing, chromatin structure modification, DNA damage, DNA
repair, and protein degradation.
RNA pol  II  has  a  unique  role  in  DNA repair.  DNA damage
surveillance protects the genome from permanent mutations oc-
curring when the chromatin is processed. The principal system to
remove DNA helix-distorting lesions is nucleotide excision repair
(NER). Two sub-pathways of NER exist that differ in the recogni-
tion of the lesion (Kamileri et al., 2012). In global-genomic NER
(GG-NER) the DNA is surveyed for lesions by specialised com-
plex XPC-RAD23-CETN2 and UV-DDB (DDB1-DDB2-containing
E3-ubiquitin ligase complex. In another sub-pathway, transcrip-
tion-coupled NER (TC-NER), the repair is initiated by stalled
RNA pol II. The final steps in both GG-NER and TC-NER are the
same, involving excision of a short fragment of the damaged
DNA strand, followed by synthesis and ligation reactions.
NER is also capable of initiating checkpoint signalling. It is me-
diated by ATR and results in p53 activation, even in non-cycling
cells (Vrouwe et al., 2011). It is likely that ssDNA formed during
the processing steps of the NER stimulates the ATR. Interestingly,
inhibition of elongating RNA pol II alone is sufficient to initiate
ATR response and activation of p53 (Ljungman et al., 1999;
Derheimer et al., 2007).
1.5 COMPARTMENTALISATION OF NUCLEI
The nucleus is highly organised both functionally and structur-
ally. Organisation can be observed at three levels: spatial and
temporal organisation of nuclear processes, higher-order organi-
sation of chromatin into domains, and the spatial organisation of
genes and chromosomes (Misteli, 2007). Compartmentalisation is
the most evident in nuclear bodies, which are spatially confined
structures fulfilling specialised tasks (Dundr, 2012). Nuclear bod-
ies are self-organised, highly dynamic, membraneless organelles
of the nucleus.
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are involved not only in RNA transcription, but also in RNA pro-
cessing, chromatin structure modification, DNA damage, DNA
repair, and protein degradation.
RNA pol  II  has  a  unique  role  in  DNA repair.  DNA damage
surveillance protects the genome from permanent mutations oc-
curring when the chromatin is processed. The principal system to
remove DNA helix-distorting lesions is nucleotide excision repair
(NER). Two sub-pathways of NER exist that differ in the recogni-
tion of the lesion (Kamileri et al., 2012). In global-genomic NER
(GG-NER) the DNA is surveyed for lesions by specialised com-
plex XPC-RAD23-CETN2 and UV-DDB (DDB1-DDB2-containing
E3-ubiquitin ligase complex. In another sub-pathway, transcrip-
tion-coupled NER (TC-NER), the repair is initiated by stalled
RNA pol II. The final steps in both GG-NER and TC-NER are the
same, involving excision of a short fragment of the damaged
DNA strand, followed by synthesis and ligation reactions.
NER is also capable of initiating checkpoint signalling. It is me-
diated by ATR and results in p53 activation, even in non-cycling
cells (Vrouwe et al., 2011). It is likely that ssDNA formed during
the processing steps of the NER stimulates the ATR. Interestingly,
inhibition of elongating RNA pol II alone is sufficient to initiate
ATR response and activation of p53 (Ljungman et al., 1999;
Derheimer et al., 2007).
1.5 COMPARTMENTALISATION OF NUCLEI
The nucleus is highly organised both functionally and structur-
ally. Organisation can be observed at three levels: spatial and
temporal organisation of nuclear processes, higher-order organi-
sation of chromatin into domains, and the spatial organisation of
genes and chromosomes (Misteli, 2007). Compartmentalisation is
the most evident in nuclear bodies, which are spatially confined
structures fulfilling specialised tasks (Dundr, 2012). Nuclear bod-
ies are self-organised, highly dynamic, membraneless organelles
of the nucleus.
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In order to pack almost two metres of DNA into each of mam-
malian cell, the DNA must be folded and compacted tightly. Pri-
mary proteins that pack the DNA are histones H3, H4, H2A, and
H2B, which form the core of nucleosomes and pack the DNA into
beads on a string, conferring 5–10-fold packing of DNA. Linker
histones (H1) further pack the chromatin fibre by connecting nu-
cleosomes into a tube-like formation. This level of packing pro-
vides 50-fold compaction for the DNA fibre. The higher-level
chromatin organisation has only recently begun to be understood
(Bickmore & van Steensel, 2013). It is becoming clear that chro-
matin is organised into domains that modulate the activity of
DNA. The DNA sequence elements, especially the repetitive
ones, are closely linked to chromatin organisation and may play
a major role in the architecture of the genome (Shapiro & von
Sternberg, 2005). The level of compaction varies in the genome
and correlates with transcriptional activity. Chromosomes are
not intermingled in the nucleus, but occupy their own space
called chromosome territory (Cremer & Cremer, 2010). Active
and inactive genomic regions tend to cluster in their own respec-
tive compartments (Bickmore & van Steensel, 2013).
In order to regulate the DNA metabolism and access DNA for
transcription and replication, the chromatin structure must be re-
structured by remodellers. Remodellers can move nucleosomes
and restructure their composition. The remodelling activity is
regulated in large part by histone modifications. Four families of
chromatin remodelling complexes are known: SWI/SNF, ISWI,
CHD, and INO80 (Clapier & Cairns, 2009). Interestingly, inhibi-
tion of E2F1 by TopBP1 occurs through TopBP1-mediated recruit-
ment of the SWI/SNF central subunit Brg1/Brm to E2F1-respon-
sive promoters (Liu et al., 2004). This suggests a role for TopBP1
in the regulation of the chromatin structure. DNA pol H also has
a role in chromatin remodelling (Pursell & Kunkel, 2008).
Most of the processes taking place in the nucleus occur in con-
fined spaces, many of them in nuclear bodies. These include the
cleavage body, nuclear speckle, nuclear stress body, OPT domain,
paraspecle, perinucleolar compartment, PML body, polycomb
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body, clastosome, cajal body, and nucleolus (Dundr, 2012). In es-
sence, DNA replication and RNA transcription occur in similar
bodies, but they are called replication or transcription factories
(Cook, 1999). Concentrating processes into defined spaces facili-
tates efficient reactions. This process takes advantage of molecu-
lar crowding, which favours stochastic interactions in molecu-
larly concentrated spaces (Richter et al., 2008).
1.6 AIMS OF THE STUDY
The aim of this thesis was to better understand the molecular
mechanisms controlling cell cycle progression. The studies con-
centrated on DNA replication and DNA damage stress response
through examination of molecular functions of TopBP1 and DNA
pol H. In particular, the effects of elevated levels of wild-type (I)
and mutant (II) TopBP1 protein on cell cycle, DNA replication
and in the cellular stress response were studied. Unexpected co-
operation of the core components of DNA replication and RNA
transcription was studied by examining the interaction between
DNA pol H and RNA pol II (III).
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2 Experimental Procedures
2.1 DNA CONSTRUCTS AND GENERATION OF CELL LINES (I,
II)
Full-length TopBP1 cDNA (complementary DNA) was initially
prepared by Dr Kaarina Reini as part of a project characterising
the functions of human TopBP1 (Mäkiniemi et al., 2001). The
TopBP1 open reading frame (ORF) was in a peGFP-C1 plasmid
(Genbank accession U55763), which is a mammalian expression
vector with cytomegalovirus promoter encoding fusion protein
with N-terminal eGFP fused to TopBP1. The correct sequence of
this construct was confirmed by sequencing it using an ABI Prism
310 Genetic Analyser.
To prepare mutant TopBP1 with tryptophan to arginine muta-
tion at 1145 (W1145R), an overlap extension PCR was used (see
Figure 2 for the site of tryptophan 1145). Briefly, PCR reactions
were prepared with one primer containing mutation and another
primer at the end of the target sequence, two reactions towards
the both ends (step 1, Figure 1). In the third PCR, the products of
the first two PCR reactions were used to complete the missing
ends (step 2). In the fourth and final PCR, the primers at the end
of the templates were used together with the PCR product from
the third PCR as a template (step 3). The cDNA of TopBP1 with
W1145R mutation was then cloned into a pEGFP-C1 vector. The
clone was sequenced to verify the correct reading frame and se-
quence.
TopBP1 deletion mutants were generated using an In-Fusion
HD EcoDry Cloning Kit (Clontech). Constructs were designed in
such a way that each contained both of the putative nuclear local-
isation signals present in the wild-type TopBP1. Deletion mutants
were cloned into a pEGFP-C1 vector.
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Initially, constitutively expressing eGFP-TopBP1 cell lines
were prepared, but the clones were not stable. Conditionally ex-
pressing clones were subsequently prepared using the Tet-On
Advanced system (Clontech). First, the lowest effective concen-
trations were determined for hygromycin (100 µg/ml) and G418
antibiotics that kill the non-transfected U2OS (human osteosar-
coma cell line) cells. Then, stable Tet-On clones were obtained
from U2OS cells transfected with pTet-On Advanced plasmid.
Eight clones were obtained and initially tested for expression by
transiently transfecting with pTRE-Tight-Luc reporter plasmid.
The clone that expressed the transgene most brightly was selected
for stable transfection. Similarly, eGFP and eGFP-TopBP1
W1145R clones were obtained by stably transfecting the same
Tet-On cells with respective pTRE-Tight vectors.
The selection of stable clones was achieved by transfecting
cells with Effectene, then growing the transfected cells for a few
days without antibiotic selection and then approximately one
week under selection. Cells were subcloned by plating at such a
low density that it was later possible to pick individual colonies.
Figure 1. Overlap extension mutagenesis scheme. See text for details.
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After formation of approximately 50 cell colonies, they were
transferred with 2 mm filter disks into a 24-well plate for further
growth.
2.2 CELL CULTURE (I, II, III) AND RNA INTERFERENCE (I)
All cells used in this study were purchased either from ATCC
(American Type Culture Collection) or ECACC (European Col-
lection of Cell Cultures). The cells were cultured in a humidified
chamber at 5% CO2 and +37°C. The growth medium was McCoy’s
5a, DMEM (Dulbecco’s Modified Eagle Medium), or EMEM (Ea-
gle’s Minimal Essential Medium), supplemented with 10% foetal
bovine serum, L-Glutamine, and Na-pyruvate. Cells were culti-
vated either under antibiotic-free conditions (I, II) or with peni-
cillin-streptomycin (III). Genetically modified cell lines were cul-
tivated in a selective medium containing G418 and hygromycin
to kill the cells that did not maintain the transgene (I, II).
To  knock  down  ATR  (I)  and  UBF  (Figure  3),  validated  (for
ATR) or pre-designed (for UBF) siRNA (Ambion) was transfected
using HiPerfect transfection reagent (Qiagen). The final concen-
trations used were 1 nM for ATR and 5 nM for UBF, transfected
a total of three times at 24-h intervals.
2.3 MICROSCOPY (I, II, III) AND FLOW CYTOMETRY (II, III)
For immunofluorescence microscopy (I, II, III), cells were quickly
rinsed with PBS and then fixed with 4% PFA (paraformaldehyde)
at room temperature. The cells were permeabilised with 0.2%
TX100-PBS and washed with PBS. The cells were then blocked
with 1% BSA-PBS or 5% goat serum (Chemicon), followed by in-
cubation in primary and secondary antibody dilutions (1:50–
1:2500 and 1:2000, respectively), each for 1 h at +37°C or at room
temperature. DNA was stained with Hoechst 33258 or DAPI.
For nascent RNA and DNA labelling (I), cells were given a 30-
min  pulse  of  either  2  mM  5’-fluorouridine  (FUrd,  Sigma)  or  5-
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For immunofluorescence microscopy (I, II, III), cells were quickly
rinsed with PBS and then fixed with 4% PFA (paraformaldehyde)
at room temperature. The cells were permeabilised with 0.2%
TX100-PBS and washed with PBS. The cells were then blocked
with 1% BSA-PBS or 5% goat serum (Chemicon), followed by in-
cubation in primary and secondary antibody dilutions (1:50–
1:2500 and 1:2000, respectively), each for 1 h at +37°C or at room
temperature. DNA was stained with Hoechst 33258 or DAPI.
For nascent RNA and DNA labelling (I), cells were given a 30-
min  pulse  of  either  2  mM  5’-fluorouridine  (FUrd,  Sigma)  or  5-
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ethynyl-2’-deoxyuridine (EdU). Incorporated FUrd was detected
from fixed cells with D-BrdU antibody, BU-33 (Sigma). Incorpo-
rated EdU was detected with a Click-iT EdUAlexa Fluor 594 Im-
aging Kit (Life Technologies).
In I and II, wide-field fluorescent images were obtained with
Axiocam HR colour using a Zeiss Axioplan 2 microscope with ei-
ther a 40× Zeiss Plan-Neofluar or 63× Zeiss Plan-Apochromat ob-
jective.  Image  acquisition  was  done  with  Axiovision  AxioVS40
software (v4.8.2). In III, images were obtained with a charge-cou-
pled device camera and Olympus BX-61 microscope with 100×
objective.
Confocal fluorescent images (I) were obtained with a Zeiss
Axio Observer inverted microscope (40× objective) equipped
with a Zeiss LSM700 confocal module (Carl Zeiss Microimaging
GmbH, Jena,  Germany).  Image acquisition was done with ZEN
2012 software (Carl Zeiss Microimaging GmbH). All images were
processed with Photoshop CS5 (12.0).
For immunoelectron microscopy (I, III), cells were fixed with
4% PFA (paraformaldehyde) in 0.1 M phosphate buffer at pH 7.5.
Cells were scraped off of the plate, rinsed with PBS, and mixed
with 12% gelatine in PBS (I) or 2% NuSieve agarose (FMC Bi-
oProducts). The specimens were frozen in liquid nitrogen, and
thin cryosections were cut with a Leica EM UC7 cryoultramicro-
tome (Leica Microsystems). The sections were blocked with BSA
and gelatine. Sections were exposed to the first primary antibody
followed by incubation with protein A–gold (5 nm). After wash-
ings, 1% glutaraldehyde in 0.1M phosphate buffer (pH 7.5) was
used to block free-binding sites on protein A. The sections were
then incubated with the second primary antibody followed by
rabbit anti-mouse IgG for 30 min (Jackson Immunoresearch La-
boratories) and then incubated in the protein A–gold (10 nm) for
30 min. The controls were prepared by replacing the primary an-
tibody with PBS. The sections were stained with neutral uranyl
acetate (UA) and then embedded in 2% methyl cellulose contain-
ing 0.4% UA and examined with a Tecnai Spirit transmission elec-
tron microscope (FEI) (I) or embedded in methylcellulose and ex-
amined with a Philips CM100 transmission electron microscope
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(FEI) (III). Images were captured by a Quemesa CCD camera
(Olympus Soft Imaging Solutions GmbH) (I) or by a charge-cou-
pled device camera equipped with TCL-EM-Menu version 3
(Tietz Video and Image Processing Systems GmbH) (III).
Automated image analysis in I was performed by counting
p53- and eGFP-TopBP1-positive cells using CellProfiler version
2.2.1 (Carpenter et al., 2006). Images for the analysis were cap-
tured as described above for immunofluorescence imaging. Over
600 cells were counted from each sample.
For flow cytometry in paper II, cells were labelled with 10µM
EdU (5-ethynyl-2’deoxyuridine) for 30 min before harvesting.
The cells were then collected either by trypsinisation or scraping
and washed with 1% BSA-PBS. The cells were fixed with 2% PFA
for 15 min on ice and permeabilised with 0.13% TX100 for 30 min
on ice. Click-reaction to detect incorporated EdU was performed
as instructed (Invitrogen). DNA was labelled with DAPI prior to
flow cytometry analysis with FACSCanto (BD Biosciences). Anal-
ysis was accomplished using FloJo software.
For flow cytometry in paper III, cells were fixed in cold 70%
ethanol for at least 30 min. The cells were then washed in PBS,
treated with ribonuclease, and stained with propidium iodide.
The cells were measured with a Becton Dickinson flow cytometer.
2.4 IMMUNOBLOTTING (I, II) AND IMMUNOPRECIPITATION
(III)
To prepare whole-cell extract for immunoblotting, cells were
washed with PBS, scraped off of the plate and suspended in TGE
buffer (50 mM Tris-HCl pH 7.9, 10% glycerol, 5 mM EDTA, 100
mM NaCl, 0.5% IGEPAL CA-630, 1 mM DTT, 1 mM NaF, 1 mM
Na3VO4, and 1x complete protease inhibitor cocktail [Roche]),
briefly sonicated, and finally cleared by centrifugation at 16 000×g
for 10 min.
For immunoblotting of fractionated cells (I), the cells were first
washed with hypotonic buffer (10 mM MOPS-NaOH pH 7.0, 10
mM NaCl, 1 mM MgCl2, 1 mM DTT) and lysed in the same buffer
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supplemented with 0.5% IGEPAL CA-630 to give detergent-solu-
ble/cytoplasmic fraction. Chromatin-bound proteins were re-
leased  by  incubating  nuclei  in  high-salt  buffer  (20  mM HEPES-
KOH pH 7.4, 500 mM NaCl, 5 mM KCl, 0.5 mM DTT, and 1x com-
plete protease inhibitor cocktail [Roche]). The remaining nuclear
material was solubilised in SDS lysis buffer (20 mM HEPES-KOH
pH 7.4, 0–5% SDS, 100 mM NaCl, 5 mM KCl, 0.5 mM MgCl2, 0.5,
DTT).
Protein concentration was determined with Bradford assay. A
total of 10–50 µg protein were separated on SDS-PAGE, trans-
ferred onto a PVDF membrane and detected using chemilumines-
cence (SuperSignal West Pico, Thermo Scientific), and exposed on
Amersham Hyperfilm ECL (GE Life Sciences).
To prepare material for immunoprecipitations, either whole
cells (III) or nuclear extract (Figure 3) was used. Whole cells were
scraped in lysis buffer 1 (100 mM Tris-HCl pH 7.5, 80 mM NaCl,
10% glycerol, 0.1% Nonidet P-40, complete protease inhibitors, 10
mM Na3VO4, and 10 mM NaF) or in lysis buffer 2 (50 mM Tris-
HCl pH 7.5, 100 mM KCl, 5% glycerol, 0.1% Nonidet P-40, com-
plete protease inhibitor, 1 mM EDTA, 10 mM NaF, 2 mM
Na3VO4). Nuclear extracts were prepared as described above by
removing soluble material with IGEPAL CA-630 lysis from cells
attached to the plate. The remaining nuclei were washed twice
with HEPES buffer (30 mM HEPES-KOH pH 7.4, 5 mM K-acetate,
0.5 mM MgCl2, 2 mM DTT) and finally suspended in TGE buffer.
Lysed material was sonicated briefly before immunoprecipita-
tion.
Both whole-cell and nuclear material was pre-cleared with
nonspecific antibodies before actual immunoprecipitation. Pro-
tein–antibody complexes were collected either with PureProte-
ome Protein G Magnetic Beads (Millipore) (Figure 3) or Gamma-
Bind protein G–Sepharose (Amersham Biosciences). Immunopre-
cipitates were washed multiple times with lysis buffer without
inhibitors (III) or with TGE buffer without inhibitors.
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2.5 QUANTITATIVE REVERSE TRANSCRIPTASE PCR (I)
Cells were lysed in Trizol (Invitrogen) and RNA was extracted as
instructed. Purified total RNA was treated with RQ1 DNase
(Promega) to remove DNA contamination. Reverse transcription
(RT) and quantitative PCR were performed with a DyNAmo
SYBR Green 2-step qRT-PCR Kit (Finnzymes/Thermo scientific).
Quantitative PCR reactions were run with an Opticon Monitor
programme in a Chromo 4 Peltier Thermal Cycler (MJ Research).
A cycle programme of 95°C for 15 min, followed by 40 cycles of
94°C for 10 s, 57°C for 30 s, and 72°C for 30 s, was used for both
primer pairs. Pre-rRNA signals were normalised to E-actin
(ACTB) signals. Primers targeting the pre-rRNA 5’ external tran-
scribed region were FWD 5’ GGAAGGAGGTGGGTGGAC 3’ and
REV 5’ GCGGTACGAGGAAACACCT 3’. Primers targeting
ACTB were FWD 5’ CTCTTCCAGCCTTCCTTCCT 3’ and REV 5’
AGCACTGTGTTGGCGTACAG 3’.
2.6 CHROMATIN IMMUNOPRECIPITATION (I)
A chromatin immunoprecipitation assay was performed as de-
scribed (Nelson et al., 2006). In brief, cells were fixed with 1% for-
malin for 10 min and lysed in 150 mM NaCl, 50 mM Tris-HCl pH
7.5, 5 mM EDTA, 0.5% IGEPAL CA-630, 1% TX-100, 1x complete
protease  inhibitor  cocktail,  1  mM NaF,  and 1  mM Na3VO4. The
resulting nuclei were sonicated with a Hielscher UP200S at 100%
amplitude for 8 rounds of 15x0.5s pulses to obtain 200–1000 bp
sheared DNA. Antibodies used in immunoprecipitations were
from Millipore (D-TopBP1 AB3245) and Santa Cruz Biotechnol-
ogy (D-RNA pol I/D-RPA194, C-1). Immunocomplexes were col-
lected with 30µl of protein G magnetic beads (Dynabeads, Life
Technologies). DNA was extracted from the beads with 10%
Chelex-resin (Bio-Rad). The input DNA sample was treated with
proteinase K (Invitrogen), ethanol-precipitated, and processed
the same way as bead-immunoprecipitates. Real-time PCR was
used to quantitate the immunoprecipitated DNA and normalised
Experimental Procedures
Dissertations in Forestry and Natural Sciences No 213 46
supplemented with 0.5% IGEPAL CA-630 to give detergent-solu-
ble/cytoplasmic fraction. Chromatin-bound proteins were re-
leased  by  incubating  nuclei  in  high-salt  buffer  (20  mM HEPES-
KOH pH 7.4, 500 mM NaCl, 5 mM KCl, 0.5 mM DTT, and 1x com-
plete protease inhibitor cocktail [Roche]). The remaining nuclear
material was solubilised in SDS lysis buffer (20 mM HEPES-KOH
pH 7.4, 0–5% SDS, 100 mM NaCl, 5 mM KCl, 0.5 mM MgCl2, 0.5,
DTT).
Protein concentration was determined with Bradford assay. A
total of 10–50 µg protein were separated on SDS-PAGE, trans-
ferred onto a PVDF membrane and detected using chemilumines-
cence (SuperSignal West Pico, Thermo Scientific), and exposed on
Amersham Hyperfilm ECL (GE Life Sciences).
To prepare material for immunoprecipitations, either whole
cells (III) or nuclear extract (Figure 3) was used. Whole cells were
scraped in lysis buffer 1 (100 mM Tris-HCl pH 7.5, 80 mM NaCl,
10% glycerol, 0.1% Nonidet P-40, complete protease inhibitors, 10
mM Na3VO4, and 10 mM NaF) or in lysis buffer 2 (50 mM Tris-
HCl pH 7.5, 100 mM KCl, 5% glycerol, 0.1% Nonidet P-40, com-
plete protease inhibitor, 1 mM EDTA, 10 mM NaF, 2 mM
Na3VO4). Nuclear extracts were prepared as described above by
removing soluble material with IGEPAL CA-630 lysis from cells
attached to the plate. The remaining nuclei were washed twice
with HEPES buffer (30 mM HEPES-KOH pH 7.4, 5 mM K-acetate,
0.5 mM MgCl2, 2 mM DTT) and finally suspended in TGE buffer.
Lysed material was sonicated briefly before immunoprecipita-
tion.
Both whole-cell and nuclear material was pre-cleared with
nonspecific antibodies before actual immunoprecipitation. Pro-
tein–antibody complexes were collected either with PureProte-
ome Protein G Magnetic Beads (Millipore) (Figure 3) or Gamma-
Bind protein G–Sepharose (Amersham Biosciences). Immunopre-
cipitates were washed multiple times with lysis buffer without
inhibitors (III) or with TGE buffer without inhibitors.
Miiko Sokka: DNA Polymerase Epsilon and TopBP1
47 Dissertations in Forestry and Natural Sciences No 213
2.5 QUANTITATIVE REVERSE TRANSCRIPTASE PCR (I)
Cells were lysed in Trizol (Invitrogen) and RNA was extracted as
instructed. Purified total RNA was treated with RQ1 DNase
(Promega) to remove DNA contamination. Reverse transcription
(RT) and quantitative PCR were performed with a DyNAmo
SYBR Green 2-step qRT-PCR Kit (Finnzymes/Thermo scientific).
Quantitative PCR reactions were run with an Opticon Monitor
programme in a Chromo 4 Peltier Thermal Cycler (MJ Research).
A cycle programme of 95°C for 15 min, followed by 40 cycles of
94°C for 10 s, 57°C for 30 s, and 72°C for 30 s, was used for both
primer pairs. Pre-rRNA signals were normalised to E-actin
(ACTB) signals. Primers targeting the pre-rRNA 5’ external tran-
scribed region were FWD 5’ GGAAGGAGGTGGGTGGAC 3’ and
REV 5’ GCGGTACGAGGAAACACCT 3’. Primers targeting
ACTB were FWD 5’ CTCTTCCAGCCTTCCTTCCT 3’ and REV 5’
AGCACTGTGTTGGCGTACAG 3’.
2.6 CHROMATIN IMMUNOPRECIPITATION (I)
A chromatin immunoprecipitation assay was performed as de-
scribed (Nelson et al., 2006). In brief, cells were fixed with 1% for-
malin for 10 min and lysed in 150 mM NaCl, 50 mM Tris-HCl pH
7.5, 5 mM EDTA, 0.5% IGEPAL CA-630, 1% TX-100, 1x complete
protease  inhibitor  cocktail,  1  mM NaF,  and 1  mM Na3VO4. The
resulting nuclei were sonicated with a Hielscher UP200S at 100%
amplitude for 8 rounds of 15x0.5s pulses to obtain 200–1000 bp
sheared DNA. Antibodies used in immunoprecipitations were
from Millipore (D-TopBP1 AB3245) and Santa Cruz Biotechnol-
ogy (D-RNA pol I/D-RPA194, C-1). Immunocomplexes were col-
lected with 30µl of protein G magnetic beads (Dynabeads, Life
Technologies). DNA was extracted from the beads with 10%
Chelex-resin (Bio-Rad). The input DNA sample was treated with
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to input dilution series. Protein G bead-only precipitations were
performed to check for the background level of DNA enrichment.
The DNA enrichment from these controls was less than 0.04% of
the input samples. Primers for ribosomal DNA were from
Grandori et al. (2005). Quantitative PCR reactions were run with
the Opticon Monitor programme in a Chromo 4 Peltier Thermal
Cycler (MJ research) using a DyNAmo SYBR Green mix
(Finnzymes) and a cycle programme of 95°C for 2 min, followed
by 40 cycles of 95°C for 30 s, 58°C for 30 s, and 72°C for 1 min, for
all primers.
2.7 DNA FIBRE ASSAY AND SSDNA ANALYSIS (II)
For DNA fibre assay, cells were supplemented with 25 µM IdU
(Sigma-Aldrich) for 45 min (first labelling), washed, and supple-
mented with 250 µM CldU (Sigma-Aldrich) in a fresh medium for
45 min (second labelling). Preparation of DNA spreads was done
as described before (Jackson, 1998), with minor modifications.
Briefly, approximately 1,000 cells were lysed on glass slides by
addition of 7 µl of lysis buffer (200 mM Tris-HCl pH 7.4, 50 mM
EDTA, 0.5 % SDS). DNA spreads were generated by slightly tilt-
ing  the  microscope  slide  and  fixed  using  methanol/acetic  acid
(3:1) after air drying. DNA spreads were denatured by incubation
with  2.5  M  HCl  for  75  min  at  RT.  The  microscope  slides  were
washed with PBS and blocked with TPB (0.1% TX-100, 1% BSA in
PBS) for 1 h. After incubation with a monoclonal rat anti-BrdU
antibody (Clone BU1/75, 1:1000) in TPB for 1 h at RT, which binds
CldU but not IdU, the slides were washed and subsequently fixed
with 4% PFA in PBS (10 min, RT), washed, and incubated with
goat anti-rat antibody conjugated with Alexa Fluor 555 (Life
Technologies, 1:500 in TPB) for 2 h at RT. DNA spreads were
washed again and incubated overnight at 4° C with a monoclonal
mouse  anti-BrdU antibody (Clone  44,  1:1500),  which  binds  IdU
but not CldU. After washing, an Alexa Fluor 488 conjugated goat
anti-mouse antibody (Life Technologies, 1:500 in TPB) was added
for 2 h at RT. Then the slides were extensively washed again and
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mounted. Pictures of fluorescent immunolabelled DNA spreads
were taken using an Axio Imager.Z1 at 400-fold magnification.
For ssDNA analysis, DNA was labelled by growing cells in 10
µM BrdU for 36 h to uniformly incorporate the nucleotide ana-
logue. The sample preparation was performed as described (Rad-
erschall, 1999). Incorporated BrdU that was exposed in the single-
stranded template strand was immunolabelled with a monoclo-
nal rat-anti-BrdU antibody (Clone BU1/75). DNA was counter-
stained with DAPI. Images were taken using the Zeiss Axio Im-
ager.Z1 at 630-fold magnification.
2.8 COLONY FORMATION ASSAY (II)
Cells were plated on a 10-cm tissue culture dish at low concentra-
tion (approximately 5,000 cells per dish) and grown with or with-
out doxycycline for 8 days until colonies of over 50 cells appeared
in the no-doxycycline control plates. Colonies were fixed with
methanol and stained with 0.5% crystal violet in 25% methanol.
The number of colonies was counted after several washes with
water using an automated analysis using CellProfiler (r11710)
(Carpenter et al., 2006).
2.9 CELL SYNCHRONISATION (II, III)
U2OS cells used in II were synchronised sequentially with 9 µM
RO-3306 (Cdk1 inhibitor) for 20 h and then with 100 nM noco-
dazole for 1 to 2 h. Treating the cells first with a Cdk1 inhibitor
RO-3306 gives an enrichment of G2 cells, resulting in a higher
proportion of metaphase-arrested cells after short nocodazole (in-
hibitor of micortubule polymerisation) treatment. This method
also reduces the toxic effects of nocodazole. Loosely attached
metaphase cells were subsequently knocked off from the plate
(mitotic shake-off), washed, and re-plated.
T98G cells used in III were synchronised at the G0 phase by
growing the cells with 0.5% serum for 3 to 6 days. Re-stimulation
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in the no-doxycycline control plates. Colonies were fixed with
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The number of colonies was counted after several washes with
water using an automated analysis using CellProfiler (r11710)
(Carpenter et al., 2006).
2.9 CELL SYNCHRONISATION (II, III)
U2OS cells used in II were synchronised sequentially with 9 µM
RO-3306 (Cdk1 inhibitor) for 20 h and then with 100 nM noco-
dazole for 1 to 2 h. Treating the cells first with a Cdk1 inhibitor
RO-3306 gives an enrichment of G2 cells, resulting in a higher
proportion of metaphase-arrested cells after short nocodazole (in-
hibitor of micortubule polymerisation) treatment. This method
also reduces the toxic effects of nocodazole. Loosely attached
metaphase cells were subsequently knocked off from the plate
(mitotic shake-off), washed, and re-plated.
T98G cells used in III were synchronised at the G0 phase by
growing the cells with 0.5% serum for 3 to 6 days. Re-stimulation
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of growth was achieved by adding equal amounts of complete
and balanced (used medium) medium.
2.10 UV CROSSLINKING (III)
UV crosslinking of proteins to nascent DNA�RNA in a monolayer
of isolated nuclei was performed as described previously (Zlotkin
et al., 1996), with minor modifications. Cells were washed with
buffer  KM  (10  mM  MOPS-NaOH  pH  7.0,  10  mM  NaCl,  1  mM
MgCl2, 2 mM DTT, 1 x complete protease inhibitor) and lysed by
incubation for 30 min on ice with buffer KM containing 0.5%
Nonidet P-40, resulting in a monolayer of isolated nuclei. The nu-
clear monolayer was then washed twice with buffer KAc (30 mM
HEPES-KOH pH 7.5, 5 mM K-acetate, 0.5 mM MgCl2, 2 mM DTT,
1 x complete protease inhibitor). The reaction mixture for UTP la-
belling contained 30 mM HEPES-KOH pH 7.8, 50 mM K-acetate,
5 mM MgCl2, 2mM DTT, 0.05% Nonidet P-40, 2 µM each of dATP,
dGTP and dCTP, 20 µM BrdUTP, 1 µM [32P]UTP[DP] (specific ac-
tivity 410 Ci/mmol), 2 mM ATP, and 10 µM CTP and GTP. Alpha-
amanitin and aphidicolin were used at 50 µg/ml. Each 6-cm plate
received 400 µl of reaction mixture, and the reactions proceeded
for  2.5  min  at  30 qC.  The  mixture  was  used  for  a  total  of  three
successive plates. After labelling, the nuclei were washed with
buffer KAc and UV-irradiated with a standard UV transillumina-
tor for 6 min. The irradiated nuclei were treated with HindIII and
PstI (100 U/ml) for 30 min at 37 qC to remove the bulk of DNA.
Protein–nucleic acid complexes were extracted with phenol, pre-
cipitated with acetone, collected at 0 qC, and washed three times.
The dried protein–nucleic acid pellet was resuspended by boiling
in denaturation buffer (50 mM Tris -  HCl pH 7.5,  0.5% SDS, 70
mM E-mercaptoethanol) and renaturated (50 mm Tris -HCl pH
7.5, 150 mM NaCl, 0.5% Nonidet P-40, 1 x complete protease in-
hibitor).
Proteins were then ready for immunoprecipitation. For im-
munoprecipitations, 7 mg of protein A- or G-Sepharose and 3 µl
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of p140 serum, 4 µl of K30 serum, and 8 lg of purified GIA anti-
body were used to precipitate, in parallel, pols D, G, and H, respec-
tively. Immunoprecipitates were washed three times with wash-
ing buffer (50 mm Tris-HCl pH 7.5, 150 mM NaCl, 0.5% Nonidet
P-40). Samples were eluted with SDS loading buffer and sepa-
rated through 6% SDS-PAGE, transferred to a polyvinylidene
difluoride membrane, and exposed to BioMax MS film (Kodak).
After autoradiography, proteins were detected using enhanced
chemiluminescence reagents (Pierce). Antibodies 1Ct102 and
2Ct25, PDG- 1E8, and a combination of G1A, H3B, and E24C were
used for detection of pols D, G, and H, respectively.
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3 Results and Discussion
The research group led by Prof Juhani Syväoja has a long history
of studying mammalian DNA replication and the function of
DNA pol H in particular. In the late 1990s, the group searched for
the human homologues for the yeast Dpb11 gene. These studies
identified TopBP1 as an interaction partner of DNA pol H and
yielded one of the first publications of the human TopBP1 de-
scribing a role for TopBP1 in DNA replication and damage re-
sponse (Mäkiniemi et al., 2001).
My original aim was to study the roles of TopBP1 in the DNA
replication phase of the cell cycle. A link between high protein
levels of TopBP1 and high tumour grade with shorter patient sur-
vival (Liu et al., 2009) led to the investigation of the role of high
cellular levels of TopBP1 in cell cycle regulation. I also partici-
pated in a study showing an interaction between DNA pol H and
the elongating form of RNA pol II (III).
3.1 TopBP1 INITIATES NUCLEOLAR STRESS RESPONSE (I)
In order to gain insight into the functions of TopBP1  I utilised the
full-length construct of the TopBP1 coding sequence that was pre-
viously prepared by Kaarina Reini (Mäkiniemi et al., 2001). By
transiently transfecting transformed and primary human cell
lines with ectopic TopBP1, diffuse nuclear localisation of the pro-
tein was seen, but also strong focal localisation in the nuclei (see
Supplementary Figure S3 in I). These TopBP1 foci were not simi-
lar to DNA damage foci that were previously reported
(Mäkiniemi et al., 2001; Yamane et al., 2002), but instead appar-
ently associated with nucleoli. Nucleoli, as primary sites for ribo-
some biogenesis, are at centre stage in a growing cell, being re-
sponsible for over 50% of the total RNA production in a cell. This
unique position raises nucleoli as ideal targets for regulation of
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cell growth and cell cycle (Rudra & Warner, 2004). An important
regulatory pathway that is under nucleolar control is the p53
pathway (Vlatkovi� et al., 2014). Nucleolar stress response is char-
acterised by cessation of rRNA transcription, reorganisation of
nucleolar components, and stabilisation of p53.
Figure 2. Schematic view of functional domains of TopBP1 protein. BRCT domains 0–
8 are depicted as grey boxes and ATR activation domain is depicted as a hatched box.
Rad9 interaction regions and the tryptophan residue 1145 essential for ATR activation
are shown.
We showed that TopBP1 associates with the transcribed region
of the rDNA gene and induces nucleolar segregation when pre-
sent in cells at high levels (I-Fig 1 and I-Fig 5). The segregation,
but not localisation, of TopBP1 to the nucleolus is dependent on
the ability of TopBP1 to activate ATR kinase (I-Fig 4). These re-
sults are consistent with a model where independent chromatin
recruitment of TopBP1 and ATR is required to initiate full ATR
response (Cimprich & Cortez, 2008). It is well established that the
9–1–1 checkpoint clamp participates in TopBP1 recruitment to
chromatin through interaction between C-terminus of Rad9 and
BRCT domains 1–2 of TopBP1 (Delacroix et al., 2007; Lee et al.,
2007), and possibly through domains 4–5 (Mäkiniemi et al., 2001).
TopBP1 is a modular protein that functionally interacts with
many proteins through its eight BRCT domains (Sokka et al.,
2010) (Figure 2). Since nucleolar segregation by high levels of
TopBP1 was dependent on BRCT domains 1–2 and 4–5, and 9–1–
1 components Rad9 and Hus1 were found in segregated nucleoli
(I-Fig 6), it is conceivable that TopBP1 is recruiting Rad9 (or the
other way round) to the nucleolar chromatin. TopBP1 and 9–1–1
interaction has been suggested to lead to a self-enforcing loop
that induces efficient ATR activation (Ohashi et al., 2014). The
most plausible scenario in conditions of excess TopBP1 is that
TopBP1 is first recruited by the 9–1–1 complex to rDNA chroma-
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tin. This creates a positive feed-back loop that results in local ac-
tivation of ATR and inhibition of rRNA transcription. The reason
why overexpressed TopBP1 accumulates at rDNA in the first
place  remains  unknown.  Possible  targets  for  TopBP1  include
RNA-DNA hybrids, G4 quadruplex complexes, and DNA lesions
that are normally generated at active rRNA genes. Our results
show that endogenous TopBP1 associates with the transcribed
rRNA  gene  repeats  (I-Fig  5D),  suggesting  a  role  for  TopBP1  in
normal function of nucleoli.
In a canonical nucleolar stress response pathway, direct inhi-
bition of rRNA transcription (by e.g. low-dose of actinomycin D
[ActD],  which  preferentially  binds  to  GC-rich  rRNA  genes)  re-
sults in nucleolar segregation, where rRNA genes constrict to the
nucleolar periphery, forming nucleolar caps that contain tran-
scription machinery, including UBF and RNA pol I (Boulon et al.,
2010; van Sluis & McStay, 2015). The end result in nucleolar seg-
regation is the stabilisation of p53 and temporary blocking of the
cell cycle (Vlatkovic et al., 2013), which in our experimental con-
ditions lasted for 4 days (I-Fig 7).
By comparing TopBP1-induced nucleolar segregation to the
well-defined effects of low-dose ActD, we showed that the nucle-
olar segregation phenotype is similar between the two models (I-
Fig 7). TopBP1-induced, as well as ActD-induced, nucleolar seg-
regation results in the redistribution of NPM (nucleophosmin)
and NCL (nucleolin) from predominantly nucleolar to pan-nu-
clear localisation and to the formation of nucleolar caps contain-
ing  UBF and RNA pol  I  (I-Fig  1  and I-Fig  2).  Both  endogenous
and ectopic TopBP1 were found to also localise at these caps (I-
Fig 3), although after ActD the effect was not as pronounced as
with overexpressed TopBP1. These caps most likely represent the
condensed, transcriptionally silenced ribosomal DNA (van Sluis
& McStay, 2015). It is not known exactly why these kinds of caps
are formed during nucleolar segregation. One possible explana-
tion is that rDNA is protected from deleterious recombination by
packing it tightly. It is known that packed heterochromatin is lo-
cated around nucleoli at the location where nucleolar caps are
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cell growth and cell cycle (Rudra & Warner, 2004). An important
regulatory pathway that is under nucleolar control is the p53
pathway (Vlatkovi� et al., 2014). Nucleolar stress response is char-
acterised by cessation of rRNA transcription, reorganisation of
nucleolar components, and stabilisation of p53.
Figure 2. Schematic view of functional domains of TopBP1 protein. BRCT domains 0–
8 are depicted as grey boxes and ATR activation domain is depicted as a hatched box.
Rad9 interaction regions and the tryptophan residue 1145 essential for ATR activation
are shown.
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interaction has been suggested to lead to a self-enforcing loop
that induces efficient ATR activation (Ohashi et al., 2014). The
most plausible scenario in conditions of excess TopBP1 is that
TopBP1 is first recruited by the 9–1–1 complex to rDNA chroma-
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tin. This creates a positive feed-back loop that results in local ac-
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place  remains  unknown.  Possible  targets  for  TopBP1  include
RNA-DNA hybrids, G4 quadruplex complexes, and DNA lesions
that are normally generated at active rRNA genes. Our results
show that endogenous TopBP1 associates with the transcribed
rRNA  gene  repeats  (I-Fig  5D),  suggesting  a  role  for  TopBP1  in
normal function of nucleoli.
In a canonical nucleolar stress response pathway, direct inhi-
bition of rRNA transcription (by e.g. low-dose of actinomycin D
[ActD],  which  preferentially  binds  to  GC-rich  rRNA  genes)  re-
sults in nucleolar segregation, where rRNA genes constrict to the
nucleolar periphery, forming nucleolar caps that contain tran-
scription machinery, including UBF and RNA pol I (Boulon et al.,
2010; van Sluis & McStay, 2015). The end result in nucleolar seg-
regation is the stabilisation of p53 and temporary blocking of the
cell cycle (Vlatkovic et al., 2013), which in our experimental con-
ditions lasted for 4 days (I-Fig 7).
By comparing TopBP1-induced nucleolar segregation to the
well-defined effects of low-dose ActD, we showed that the nucle-
olar segregation phenotype is similar between the two models (I-
Fig 7). TopBP1-induced, as well as ActD-induced, nucleolar seg-
regation results in the redistribution of NPM (nucleophosmin)
and NCL (nucleolin) from predominantly nucleolar to pan-nu-
clear localisation and to the formation of nucleolar caps contain-
ing  UBF and RNA pol  I  (I-Fig  1  and I-Fig  2).  Both  endogenous
and ectopic TopBP1 were found to also localise at these caps (I-
Fig 3), although after ActD the effect was not as pronounced as
with overexpressed TopBP1. These caps most likely represent the
condensed, transcriptionally silenced ribosomal DNA (van Sluis
& McStay, 2015). It is not known exactly why these kinds of caps
are formed during nucleolar segregation. One possible explana-
tion is that rDNA is protected from deleterious recombination by
packing it tightly. It is known that packed heterochromatin is lo-
cated around nucleoli at the location where nucleolar caps are
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Figure 3. UBF interacts with TopBP1 in vivo and is required for its focal localisation.
(A) Immunoprecipitation (IP) with anti-eGFP or anti-UBF antibodies from nuclear ex-
tracts of cells that were induced to express eGFP (G) or eGFP-TopBP1 (T) for 24 h prior
to assay. Input is the cellular extract before immunoprecipitation. (B) eGFP-TopBP1
cells transfected with UBF siRNA #1 or #2 or unspecific siRNA (NEG siRNA) or left
untransfected (Control). Expression of eGFP-TopBP1 was induced for 24 h before fixing
the cells. DNA was stained with Hoechst 33258. Scale bar is 10 µm. (C) Immunoblot of
the whole-cell extracts from B. (D) Mean number (± standard deviation) of TopBP1 foci
per cell from B. Results are means of three independent experiments (more than 70 nu-
clei were counted in each experiment).
formed. Transcriptionally inactive pseudo-NORs appear in in-
terphase nuclei as tightly packed bodies, similar to ActD-induced
nucleolar caps. It has been proposed that these nucleolar caps and
pseudo-NOR bodies are related phenomena that depend on UBF
(Prieto & McStay, 2008). Interestingly, we found that UBF and
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eGFP-TopBP1 interacted in cells (Figure 3). UBF and eGFP-
TopBP1 were reciprocally co-immunoprecipitated from cells
(Figure 3A). Depletion of UBF by siRNA reduced the focal locali-
sation of TopBP1, suggesting that UBF is involved in the nucleo-
lar segregation (Figure 3B–D). The ability of TopBP1–ATR to in-
duce  nucleolar  segregation  suggests  a  role  in  remodelling  the
chromatin structure from an active open state to a condensed and
transcriptionally repressed state.
Surprisingly, while ActD induced robust p53 activation, in-
crease in p21 levels, and replicative arrest lasting for several days,
high levels of TopBP1 resulted only in local accumulation of acti-
vated p53 and a modest increase in p53 levels, but no replication
arrest (I-Fig 7). However, the lack of p53 checkpoint arrest under
high levels of TopBP1 is consistent with the negative effect of
TopBP1 on p53 transcriptional targets (Liu et al., 2009).
Taken together, our results show that the TopBP1–ATR path-
way can activate nucleolar stress response. Others have reported
inhibition of RNA pol I through different stress sensors leading
to nucleolar stress response (Mayer et al., 2005; Kruhlak et al.,
2007; Larsen et al., 2014; van Sluis & McStay, 2015). These findings
add to the evidence that the nucleolar stress response pathway is
efficiently exploited by different cellular stress signalling path-
ways through a common mechanism by inhibition of transcrip-
tion by RNA pol I.
3.2 TOPBP1 CONTROLS CELL-CYCLE PROGRESSION AT G1
AND S (II)
Human TopBP1 was initially characterised to function in DNA
damage response and DNA replication and to be essential for cell
survival (Mäkiniemi et al., 2001; Yamane et al., 2002). Identifica-
tion of TopBP1 as an essential component for activation of ATR
was a big leap in understanding the function of both ATR and
TopBP1 (Kumagai et al., 2006).
The main target in ATR signalling is Chk1 kinase, which is re-
sponsible for the global effects of ATR activation (Cimprich &
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eGFP-TopBP1 interacted in cells (Figure 3). UBF and eGFP-
TopBP1 were reciprocally co-immunoprecipitated from cells
(Figure 3A). Depletion of UBF by siRNA reduced the focal locali-
sation of TopBP1, suggesting that UBF is involved in the nucleo-
lar segregation (Figure 3B–D). The ability of TopBP1–ATR to in-
duce  nucleolar  segregation  suggests  a  role  in  remodelling  the
chromatin structure from an active open state to a condensed and
transcriptionally repressed state.
Surprisingly, while ActD induced robust p53 activation, in-
crease in p21 levels, and replicative arrest lasting for several days,
high levels of TopBP1 resulted only in local accumulation of acti-
vated p53 and a modest increase in p53 levels, but no replication
arrest (I-Fig 7). However, the lack of p53 checkpoint arrest under
high levels of TopBP1 is consistent with the negative effect of
TopBP1 on p53 transcriptional targets (Liu et al., 2009).
Taken together, our results show that the TopBP1–ATR path-
way can activate nucleolar stress response. Others have reported
inhibition of RNA pol I through different stress sensors leading
to nucleolar stress response (Mayer et al., 2005; Kruhlak et al.,
2007; Larsen et al., 2014; van Sluis & McStay, 2015). These findings
add to the evidence that the nucleolar stress response pathway is
efficiently exploited by different cellular stress signalling path-
ways through a common mechanism by inhibition of transcrip-
tion by RNA pol I.
3.2 TOPBP1 CONTROLS CELL-CYCLE PROGRESSION AT G1
AND S (II)
Human TopBP1 was initially characterised to function in DNA
damage response and DNA replication and to be essential for cell
survival (Mäkiniemi et al., 2001; Yamane et al., 2002). Identifica-
tion of TopBP1 as an essential component for activation of ATR
was a big leap in understanding the function of both ATR and
TopBP1 (Kumagai et al., 2006).
The main target in ATR signalling is Chk1 kinase, which is re-
sponsible for the global effects of ATR activation (Cimprich &
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Cortez, 2008). When the replication fork stalls or collapses due to
DNA damage or a physical obstacle, ATR and TopBP1 are inde-
pendently recruited to the sites of damage. The physical contact
among ATR, ATRIP (ATR interacting protein), and TopBP1 leads
to signal amplification and activation of Chk1. Chk1 is released
from the chromatin and diffused throughout the nucleus, where
it inhibits activation of new replication domains through actions
on Cdc25 and Wee1 (Sørensen & Syljuåsen, 2012). DNA replica-
tion follows a strict temporal and spatial programme, where
DNA is replicated within replication factories that include multi-
ple replication forks. When replication forks encounter problems,
ATR signalling activates dormant origins within the active do-
main, but at the same time prevents activation of new replication
domains. This signalling mechanism ensures that the DNA repli-
cation is completed in active domains and prevents further po-
tential damage by inhibiting replication globally. How these local
(acting at the site of DNA lesion) and global (genome-wide) ef-
fects of ATR are regulated is not well understood.
The ATR activation can be abolished by a single tryptophan to
arginine mutation at 1145 (W1145R) in TopBP1 (Kumagai et al.,
2006). To better understand the TopBP1-ATR signalling pathway
during the cell cycle and in DNA replication, a cell line that con-
ditionally expresses the ATR activation defective point mutant of
TopBP1 was prepared (TopBP1 W1145R). We found that during
DNA replication, TopBP1 W1145R acted dominant-negatively,
increasing the number of fired origins and decreasing the dis-
tance between activated origins (II-Fig 2). At the same time, rep-
lication fork speed was slowed down and the fork symmetry ratio
perturbed, indicating defects in elongation of the forks and fork
stalling (II-Fig 2). Similar effects have been observed when Chk1
or ATR is inhibited (Shechter et al., 2004; Petermann et al., 2006;
Petermann et al., 2010), and thus our results can directly be at-
tributed to the inability of TopBP1 to activate ATR. However, the
essential role of TopBP1 in restricting the excess of origin firing
has not been previously described.
We also followed TopBP1 W1145R expressing cells in the cell
cycle and observed that a large number of cells stopped in the G1
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phase (II-Fig 1). This arrest in G1 was accompanied by increase in
p21 and p27 cell-cycle inhibitors (II-Fig 1E). When expressed for
a prolonged time, TopBP1 W1145R caused the cells to exit from
the cell cycle and enter senescence, as shown by the increase in
senescence-associated E-galactosidase activity (II-Fig 1F). While
the inability of TopBP1 W1145R cells to enter the S phase could
be caused by DNA damage inflicted in the previous S phase, it
could also mean that TopBP1-ATR signalling is required for entry
into the S phase. We tested this by synchronising the cells in the
late M phase and releasing them in medium which promoted ex-
pression of either WT or W1145R of TopBP1. The expression of
TopBP1 W1145R reduced the appearance of cyclin A and phos-
phorylated Rb, indicating that the cells were unable to pass the
restriction point (II-Fig 3). This inhibitory effect was more clearly
demonstrated by including ATR inhibitor in the release medium,
suggesting that an intact ATR pathway is required for the cells to
proceed in the cell cycle.
Our findings show that TopBP1-induced ATR signalling is re-
quired at two independent points during the cell cycle: 1) in the S
phase to balance the number of active forks within an active rep-
lication domain and 2) in the G1 phase to pass the restriction
point (II-Fig 3D).
TopBP1 has previously been suggested to be required for G1
to S phase progression (Jeon et al., 2007). The authors found that
inhibition of  TopBP1 by siRNA led to up-regulation of  p21 and
p27, which resulted in down-regulation of cyclin E. This inhibi-
tory effect of TopBP1 down-regulation is contradictory to another
finding where siRNA-mediated depletion of TopBP1 did not pre-
vent entry into the S phase (Kim et al., 2005). It is possible that the
TopBP1 checkpoint function is more sensitive to protein levels
than DNA replication initiation function.
The current literature indicates opposing roles for TopBP1 in
either promotion or inhibition of cell-cycle progression. The
strong inhibitory effect on passing the restriction point of ATR-
deficient cells suggests that cells monitor the integrity of the ATR
pathway before entering a new cell cycle. This could be a way for
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phorylated Rb, indicating that the cells were unable to pass the
restriction point (II-Fig 3). This inhibitory effect was more clearly
demonstrated by including ATR inhibitor in the release medium,
suggesting that an intact ATR pathway is required for the cells to
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Our findings show that TopBP1-induced ATR signalling is re-
quired at two independent points during the cell cycle: 1) in the S
phase to balance the number of active forks within an active rep-
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point (II-Fig 3D).
TopBP1 has previously been suggested to be required for G1
to S phase progression (Jeon et al., 2007). The authors found that
inhibition of  TopBP1 by siRNA led to up-regulation of  p21 and
p27, which resulted in down-regulation of cyclin E. This inhibi-
tory effect of TopBP1 down-regulation is contradictory to another
finding where siRNA-mediated depletion of TopBP1 did not pre-
vent entry into the S phase (Kim et al., 2005). It is possible that the
TopBP1 checkpoint function is more sensitive to protein levels
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deficient cells suggests that cells monitor the integrity of the ATR
pathway before entering a new cell cycle. This could be a way for
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cells to ensure that the replication phase is possible to complete
with minimal damage to the genome.
Single-nucleotide polymorphisms of TopBP1 gene have been
linked to increased risk of breast, ovarian and endometrial can-
cers (Karppinen et al., 2006; Forma et al., 2013; Forma et al., 2014).
Furthermore, high TopBP1 protein expression levels have been
linked with negative prognosis in breast cancer (Liu et al., 2009)
and non-small cell lung cancer patients (Wang et al., 2015). These
findings, together with the finding of a potentially therapeutic
lead compound that blocks TopBP1 function (Chowdhury et al.,
2014), provide support for targeting TopBP1 to treat cancer.
3.3 RNA POL II AND DNA POL H PHYSICALLY INTERACT (III)
DNA replication and RNA transcription are the two major pro-
cesses in the cell nucleus that require chromatin opening and un-
winding of the DNA duplex. Both of these processes are also in-
timately linked to DNA repair, as the chromatin modifications
poise the DNA to lesions. Polymerases are at centre stage in tran-
scription and replication, where they coordinate the respective
processes. DNA pol H is responsible for the leading strand syn-
thesis at the active replication fork. RNA pol II is the main poly-
merase to transcribe all the messenger RNAs in the cell.
We showed an interaction between the core polymerases of
DNA replication and RNA transcription machinery. DNA pol H,
but not D or G, reciprocally co-immunoprecipitated with an elon-
gating, hyperphosphorylated form of RNA pol II (III-Fig 1 and 2).
We also observed substantial co-localisation between the two pol-
ymerases at the ultrastructural level (III-Fig 4). These two poly-
merases appear to form a stable complex, which is reflected by
the fact that they can be co-purified through three column purifi-
cation steps used for DNA pol H purification from HeLa cells
(data not shown). The specificity of the interaction of DNA pol H
with the hyperphosphorylated elongating form of RNA pol II
suggests that the interaction takes place at active transcription
centres. Further support for this notion is provided by the use of
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chemical inhibitors, specifically inhibiting initiation of transcrip-
tion (DRB, roscovitine) or elongation (D-Amanitin) (III-Fig 2).
DRB and roscovitine prevent the phosphorylation of RNA pol II
CTD by Cdks, thus blocking the RNA pol II complex at the pro-
moter region of DNA (Kim et al., 2001; Schang, 2004). In contrast,
D-Amanitin inhibits both initiation and elongation by blocking
the translocation of DNA and RNA through the RNA pol II en-
zyme (Wang et al., 2013). Treatment of cells with DRB or rosco-
vitine reduced the hyperphosphorylated form of RNA Pol II and
also the co-immunoprecipitating DNA pol H (III-Fig 2C). The in-
hibitor D-Amanitin did not have an effect on the RNA pol II hy-
perphosphorylation or co-immunoprecipitating DNA pol H (III-
Fig 2C). Consistently with the specificity of the interaction with
elongating RNA pol II, DNA pol H could be cross-linked to nas-
cent RNA that was not from RNA primers used in initiation of
DNA replication (III-Fig 3).
During DNA replication, there are collisions between the tran-
scription and the replication apparati, as both use DNA as a tem-
plate (Bermejo et al., 2012). To prevent detrimental consequences
to genome integrity, replication and transcription must be tightly
regulated. It is unlikely though that the interaction between RNA
pol II and DNA pol H is required for such a regulation. The effi-
ciency of co-immunoprecipitation was not restricted to the S
phase of the cell cycle, but was also observed in serum-starved
quiescent G0 cells and in G1 cells after the re-stimulation of
growth (III-Fig 6A). Furthermore, treatment of cells with DNA
polymerase (D, G, and H) inhibitor aphidicolin did not affect the
extent of the interaction (III-Fig 6B). Rather, strong selective asso-
ciation of DNA pol H with the elongating RNA Pol II and nascent
transcripts suggests a more fundamental role for DNA pol H dur-
ing RNA pol II transcription.
The RNA pol II CTD is comprised of up to 52 repeats of hep-
tapeptide consensus sequence with five potential phosphoryla-
tion sites (Egloff & Murphy, 2008). However, in vivo, phosphory-
lation occurs preferentially at three serine residues at sites 2, 5
and 7. CTD provides a docking platform for many nuclear factors
that regulate transcription and co-transcriptional processing of
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Fig 2C). Consistently with the specificity of the interaction with
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During DNA replication, there are collisions between the tran-
scription and the replication apparati, as both use DNA as a tem-
plate (Bermejo et al., 2012). To prevent detrimental consequences
to genome integrity, replication and transcription must be tightly
regulated. It is unlikely though that the interaction between RNA
pol II and DNA pol H is required for such a regulation. The effi-
ciency of co-immunoprecipitation was not restricted to the S
phase of the cell cycle, but was also observed in serum-starved
quiescent G0 cells and in G1 cells after the re-stimulation of
growth (III-Fig 6A). Furthermore, treatment of cells with DNA
polymerase (D, G, and H) inhibitor aphidicolin did not affect the
extent of the interaction (III-Fig 6B). Rather, strong selective asso-
ciation of DNA pol H with the elongating RNA Pol II and nascent
transcripts suggests a more fundamental role for DNA pol H dur-
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The RNA pol II CTD is comprised of up to 52 repeats of hep-
tapeptide consensus sequence with five potential phosphoryla-
tion sites (Egloff & Murphy, 2008). However, in vivo, phosphory-
lation occurs preferentially at three serine residues at sites 2, 5
and 7. CTD provides a docking platform for many nuclear factors
that regulate transcription and co-transcriptional processing of
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RNA. The phosphorylation of the CTD occurs after initiation of
RNA transcription (Egloff & Murphy, 2008). In our study, co-im-
munoprecipitation of DNA pol H was observed with different
phosphospecific antibodies recognising either serine 5 only or
serine 5 and serine 2 phosphorylated forms of the RNA pol II
CTD domain. Thus, while these results suggest that serine 5 phos-
phorylation is sufficient for the interaction, they do not rule out
the possibility that also serine 2 phosphorylation can mediate the
interaction.
A major DNA repair  pathway, NER repairs bulky,  helix dis-
torting DNA lesions through a series of reactions involving a 24–
32 nucleotide excision around the damage site and the final DNA
synthesis  step performed by DNA pol G or H. DNA damage en-
countered during RNA transcription results in initiation of TC-
NER, which is activated by the stalled, hyperphosphorylated
RNA pol IIO complex (Lainé & Egly, 2006).
It is conceivable that the interaction between RNA pol IIO and
DNA pol H is due to close participation of these two protein com-
plexes in the TC-NER. To inspect this possibility, we irradiated
cells through micropore filters to create localised DNA damage.
As expected, we detected the appearance of concentrated XPB
and CPD, as well as faint localisation of DNA pol H, in sub-nuclear
regions representing irradiated areas (III-Fig 5). However, we
could not detect accumulation of RNA pol IIO in these sites. A
lack of RNA pol II at irradiated regions does not necessarily mean
that DNA pol H–RNA Pol II interaction is not linked to NER. The
activation of TC-NER would not inevitably be expected when
DNA damage is exogenously generated, because the high
amounts of DNA damage rapidly activate global DNA repair
mechanisms. Therefore, the function of the DNA pol H–RNA pol
II interaction in NER should be investigated by using more direct
approaches.
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4 Conclusions
DNA pol H and TopBP1 are important proteins for DNA replica-
tion and cell cycle. They are both essential in the DNA replication
initiation process. Three studies described in this thesis reveal
surprising links between DNA replication, stress response, and
RNA metabolism. The finding that DNA pol H and elongating
RNA pol II physically interact throughout the cell cycle suggests
a more fundamental information flow between the two polymer-
ases than is currently appreciated (III). Future studies should in-
vestigate the exact nature of this exchange of information. We
have only touched the surface of understanding the regulatory
mechanisms affecting cell proliferation. The fact that it was only
15 or so years ago that it was first proposed that nucleoli could
serve a function other than ribosome production shows how little
we know of the interplay between different processes taking
place inside the nucleus. Here, I have linked TopBP1, previously
described to function merely in the regulation of DNA replication
and DNA damage response, to a more general stress response
system controlled by the nucleolus (I).
The results described in II highlight the importance of the reg-
ulation of TopBP1 protein levels in controlling the cell-cycle
events and suggest that the cell-cycle arresting and promoting
functions of TopBP1 are carefully balanced in cells. We propose
that the functionality of the TopBP1–ATR network is required for
cells to pass the restriction point. This would mean that cells ac-
tively monitor the integrity of one of the most critical DNA repli-
cation checkpoint systems before allowing a cell to commit to a
new cell cycle and ultimately to division.
The most fundamental feature of tumour cells is genomic in-
stability, which drives the further evolution of these cells. It is be-
coming increasingly evident that perturbations in DNA replica-
tion are behind the genomic instability observed in tumour cells
(Macheret & Halazonetis, 2015) and that all the other hallmarks
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of cancer (Hanahan & Weinberg, 2011) are subjective to genomic
instability. The exploitation of DNA replication stress is already
being pursued to treat cancer (Dobbelstein & Sørensen, 2015).
Therefore, the results presented in this thesis also potentially
have clinical value.
The whys and hows of cancer development have long puzzled
humans. Slowly, we are gaining better descriptions of the cellular
and molecular phenomena behind those processes. Understand-
ing the cell proliferation not only provides potential cures for can-
cer but other diseases as well. However, as our understanding of
biological phenomena grows, the more complex they appear: the
cells truly are more than the sum of their parts.
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